MELK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O14545 | S191 | Sugiyama | TRAFD1 FLN29 | QIEALDPPMRLPRRPLRAFEsDVFHNRTTNQRNITAQVSIQ |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15226 | T620 | Sugiyama | NKRF ITBA4 NRF | KIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQIA |
| O15530 | T354 | SIGNOR|EPSD | PDPK1 PDK1 | GPLKAHPFFESVTWENLHQQtPPKLTAYLPAMSEDDEDCyG |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S406 | EPSD|PSP | EIF4B | KLQRQLDEPKLERRPRERHPsWRsEEtQERERsRtGsEssQ |
| P23588 | S422 | EPSD|PSP | EIF4B | ERHPsWRsEEtQERERsRtGsEssQtGtstTssRNARRREs |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P30305 | S169 | GPS6|SIGNOR|EPSD|PSP | CDC25B CDC25HU2 | FQsMPVRLLGHsPVLRNItNsQAPDGRRKsEAGSGAAssSG |
| P30305 | S219 | SIGNOR | CDC25B CDC25HU2 | FKMPWKPTHPsSTHALAEWAsRREAFAQRPssAPDLMCLsP |
| P30305 | S321 | EPSD | CDC25B CDC25HU2 | LEKEEEKDLVMYSKCQRLFRsPsMPCSVIRPILKRLERPQD |
| P30305 | S323 | GPS6|EPSD|PSP | CDC25B CDC25HU2 | KEEEKDLVMYSKCQRLFRsPsMPCSVIRPILKRLERPQDRD |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35268 | Y114 | Sugiyama | RPL22 | NNLRDWLRVVANSKESYELRyFQINQDEEEEEDED______ |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q06210 | T263 | Sugiyama | GFPT1 GFAT GFPT | QGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDASA |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q14257 | Y39 | Sugiyama | RCN2 ERC55 | AAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKLGH |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14680 | S171 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MELK KIAA0175 | FGLCAKPKGNKDyHLQtCCGsLAYAAPELIQGKSYLGSEAD |
| Q14680 | S253 | GPS6|EPSD|PSP | MELK KIAA0175 | SPSSILLLQQMLQVDPKKRIsMKNLLNHPWIMQDYNyPVEW |
| Q14680 | S336 | GPS6|EPSD|PSP | MELK KIAA0175 | TYLLLLAKKARGKPVRLRLssFsCGQAsAtPFTDIKSNNWs |
| Q14680 | S343 | GPS6|EPSD|PSP | MELK KIAA0175 | KKARGKPVRLRLssFsCGQAsAtPFTDIKSNNWsLEDVtAs |
| Q14680 | S356 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MELK KIAA0175 | sFsCGQAsAtPFTDIKSNNWsLEDVtAsDKNyVAGLIDYDW |
| Q14680 | S363 | Sugiyama | MELK KIAA0175 | sAtPFTDIKSNNWsLEDVtAsDKNyVAGLIDYDWCEDDLST |
| Q14680 | S391 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | LIDYDWCEDDLSTGAAtPRTsQFTKyWtEsNGVEsKsLtPA |
| Q14680 | S405 | EPSD|PSP | MELK KIAA0175 | AAtPRTsQFTKyWtEsNGVEsKsLtPALCRtPANKLKNKEN |
| Q14680 | S407 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | tPRTsQFTKyWtEsNGVEsKsLtPALCRtPANKLKNKENVY |
| Q14680 | S431 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | ALCRtPANKLKNKENVYtPKsAVKNEEyFMFPEPKtPVNKN |
| Q14680 | S505 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | NSTGTDKLMtGVIsPERRCRsVELDLNQAHMEEtPKRKGAK |
| Q14680 | S529 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | DLNQAHMEEtPKRKGAKVFGsLERGLDKVItVLTRSKRKGS |
| Q14680 | T167 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | KLIDFGLCAKPKGNKDyHLQtCCGsLAYAAPELIQGKSYLG |
| Q14680 | T361 | Sugiyama | MELK KIAA0175 | QAsAtPFTDIKSNNWsLEDVtAsDKNyVAGLIDYDWCEDDL |
| Q14680 | T387 | EPSD|PSP | MELK KIAA0175 | yVAGLIDYDWCEDDLSTGAAtPRTsQFTKyWtEsNGVEsKs |
| Q14680 | T398 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MELK KIAA0175 | EDDLSTGAAtPRTsQFTKyWtEsNGVEsKsLtPALCRtPAN |
| Q14680 | T409 | EPSD|PSP | MELK KIAA0175 | RTsQFTKyWtEsNGVEsKsLtPALCRtPANKLKNKENVYtP |
| Q14680 | T494 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | CLKEtPIKIPVNSTGTDKLMtGVIsPERRCRsVELDLNQAH |
| Q14680 | T539 | GPS6|SIGNOR|EPSD|PSP | MELK KIAA0175 | PKRKGAKVFGsLERGLDKVItVLTRSKRKGSARDGPRRLKL |
| Q14680 | T56 | GPS6|EPSD|PSP | MELK KIAA0175 | MVAIKIMDKNTLGSDLPRIKtEIEALKNLRHQHICQLYHVL |
| Q14680 | Y163 | EPSD|PSP | MELK KIAA0175 | YHKLKLIDFGLCAKPKGNKDyHLQtCCGsLAYAAPELIQGK |
| Q14680 | Y367 | EPSD|PSP | MELK KIAA0175 | FTDIKSNNWsLEDVtAsDKNyVAGLIDYDWCEDDLSTGAAt |
| Q14680 | Y396 | Sugiyama | MELK KIAA0175 | WCEDDLSTGAAtPRTsQFTKyWtEsNGVEsKsLtPALCRtP |
| Q14680 | Y438 | EPSD|PSP|Sugiyama | MELK KIAA0175 | NKLKNKENVYtPKsAVKNEEyFMFPEPKtPVNKNQHKREIL |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q15818 | S93 | Sugiyama | NPTX1 | LSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQPGS |
| Q15910 | S220 | SIGNOR|PSP | EZH2 KMT6 | QKDLEDHRDDKESRPPRKFPsDKIFEAISSMFPDKGTAEEL |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8WUF5 | S102 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | RGsPRKAATDGADtPFGRsEsAPtLHPysPLsPKGRPssPR |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99683 | T838 | GPS6|EPSD | MAP3K5 ASK1 MAPKKK5 MEKK5 | LKISDFGtSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGY |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9H0H5 | S257 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | ETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGt |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HD42 | S101 | Sugiyama | CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1 | TMKGVTKNMAQVTKALDKALsTMDLQKVSSVMDRFEQQVQN |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9P1Y5 | S431 | Sugiyama | CAMSAP3 KIAA1543 | FGLDSDVDVVMGDPVLLRsVssDsLGPPRPAPARTPtQPPP |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 2.993491e-10 | 9.524 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.135695e-09 | 8.945 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.806986e-09 | 8.743 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.450126e-09 | 8.352 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.839525e-09 | 8.165 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.710734e-09 | 8.013 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.823040e-08 | 7.549 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.777699e-08 | 7.321 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.827207e-07 | 6.738 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.791399e-07 | 6.554 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.942628e-07 | 6.531 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.065793e-07 | 6.217 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.649124e-06 | 5.783 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.880412e-06 | 5.726 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.472872e-06 | 5.607 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.496941e-06 | 5.603 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.523098e-06 | 5.453 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.038595e-06 | 5.298 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.700883e-06 | 5.244 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.144920e-06 | 5.146 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.696030e-06 | 5.114 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.004824e-05 | 4.998 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.004824e-05 | 4.998 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.220961e-05 | 4.913 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.613826e-05 | 4.792 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.028944e-05 | 4.693 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.147339e-05 | 4.668 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.670687e-05 | 4.573 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.727312e-05 | 4.564 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.504126e-05 | 4.455 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.602091e-05 | 4.443 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.360565e-05 | 4.360 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.363451e-05 | 4.271 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.857501e-05 | 4.232 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.965815e-05 | 4.099 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.767082e-05 | 4.057 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.038089e-05 | 4.044 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.908956e-05 | 4.004 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.182410e-04 | 3.927 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.340083e-04 | 3.873 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.403726e-04 | 3.853 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.491972e-04 | 3.826 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.556583e-04 | 3.808 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.896212e-04 | 3.722 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.866925e-04 | 3.729 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.319412e-04 | 3.635 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.319412e-04 | 3.635 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.370995e-04 | 3.359 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.477089e-04 | 3.349 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.374526e-04 | 3.359 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.646572e-04 | 3.333 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.930914e-04 | 3.307 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.114811e-04 | 3.214 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.114811e-04 | 3.214 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.128921e-04 | 3.213 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.195275e-04 | 3.143 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.552850e-04 | 3.068 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.508920e-04 | 3.022 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.785686e-04 | 3.009 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.003990e-03 | 2.998 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.043563e-03 | 2.981 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.008752e-03 | 2.996 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.098312e-03 | 2.959 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.136050e-03 | 2.945 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.213812e-03 | 2.916 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.312407e-03 | 2.882 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.610094e-03 | 2.793 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.921671e-03 | 2.716 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.925199e-03 | 2.716 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.022943e-03 | 2.694 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.167431e-03 | 2.664 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.590791e-03 | 2.587 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.590791e-03 | 2.587 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.719037e-03 | 2.566 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.391496e-03 | 2.621 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.917305e-03 | 2.535 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.390065e-03 | 2.470 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.545404e-03 | 2.450 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.625582e-03 | 2.441 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.597566e-03 | 2.444 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.821395e-03 | 2.418 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.877913e-03 | 2.411 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.877913e-03 | 2.411 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.877913e-03 | 2.411 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.877913e-03 | 2.411 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.810660e-03 | 2.419 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.057226e-03 | 2.392 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.356253e-03 | 2.361 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.386247e-03 | 2.358 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.395262e-03 | 2.357 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.765850e-03 | 2.322 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.881399e-03 | 2.311 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.045440e-03 | 2.297 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.045440e-03 | 2.297 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.045440e-03 | 2.297 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.045440e-03 | 2.297 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.137840e-03 | 2.289 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.381024e-03 | 2.269 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.644430e-03 | 2.248 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.679500e-03 | 2.246 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.732600e-03 | 2.242 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.236948e-03 | 2.205 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.277925e-03 | 2.202 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.345491e-03 | 2.198 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.983789e-03 | 2.156 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.950839e-03 | 2.158 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.416238e-03 | 2.130 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 8.069499e-03 | 2.093 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.069499e-03 | 2.093 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.663415e-03 | 2.062 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.663415e-03 | 2.062 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.399064e-03 | 2.076 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.119868e-03 | 2.090 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.702918e-03 | 2.060 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.399064e-03 | 2.076 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.292023e-03 | 2.081 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.050795e-03 | 2.043 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.530807e-03 | 2.021 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.630043e-03 | 2.016 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.005091e-02 | 1.998 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.061409e-02 | 1.974 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.005070e-02 | 1.998 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.005070e-02 | 1.998 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.035357e-02 | 1.985 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.050043e-02 | 1.979 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.055573e-02 | 1.977 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.005091e-02 | 1.998 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.071099e-02 | 1.970 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.077979e-02 | 1.967 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.117614e-02 | 1.952 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.117614e-02 | 1.952 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.118644e-02 | 1.951 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.118644e-02 | 1.951 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.172443e-02 | 1.931 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.203676e-02 | 1.919 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.204688e-02 | 1.919 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.315714e-02 | 1.881 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.315714e-02 | 1.881 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.315714e-02 | 1.881 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.315714e-02 | 1.881 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.324655e-02 | 1.878 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.341294e-02 | 1.872 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.368305e-02 | 1.864 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.437264e-02 | 1.842 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.489610e-02 | 1.827 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.494760e-02 | 1.825 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.497052e-02 | 1.825 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.509396e-02 | 1.821 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.509396e-02 | 1.821 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.545658e-02 | 1.811 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.572097e-02 | 1.804 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.778413e-02 | 1.750 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.694450e-02 | 1.771 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.660164e-02 | 1.780 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.791247e-02 | 1.747 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.809187e-02 | 1.743 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.828424e-02 | 1.738 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.904913e-02 | 1.720 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.910464e-02 | 1.719 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.911591e-02 | 1.719 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.918344e-02 | 1.717 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.984263e-02 | 1.702 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.993988e-02 | 1.700 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.993988e-02 | 1.700 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.993988e-02 | 1.700 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.148865e-02 | 1.668 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.254855e-02 | 1.647 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.093320e-02 | 1.679 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.172933e-02 | 1.663 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.187854e-02 | 1.660 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.230496e-02 | 1.652 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.064928e-02 | 1.685 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.172933e-02 | 1.663 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.198780e-02 | 1.658 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.266701e-02 | 1.645 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.266740e-02 | 1.645 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.272079e-02 | 1.644 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.272079e-02 | 1.644 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.272079e-02 | 1.644 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.272079e-02 | 1.644 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.408645e-02 | 1.618 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.551861e-02 | 1.593 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.564840e-02 | 1.591 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.587459e-02 | 1.587 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.598002e-02 | 1.585 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.712957e-02 | 1.567 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.971557e-02 | 1.527 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.800567e-02 | 1.553 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.992983e-02 | 1.524 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.077642e-02 | 1.512 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.077642e-02 | 1.512 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.082815e-02 | 1.511 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.082815e-02 | 1.511 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.180960e-02 | 1.497 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.219415e-02 | 1.492 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.245776e-02 | 1.489 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.299895e-02 | 1.481 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.306848e-02 | 1.481 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.342711e-02 | 1.476 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.650116e-02 | 1.438 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.650116e-02 | 1.438 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.650116e-02 | 1.438 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.552132e-02 | 1.450 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.552132e-02 | 1.450 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.634510e-02 | 1.440 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.878974e-02 | 1.411 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.517169e-02 | 1.454 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.517169e-02 | 1.454 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.933613e-02 | 1.405 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.634510e-02 | 1.440 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.933613e-02 | 1.405 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.504124e-02 | 1.455 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.517169e-02 | 1.454 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.517169e-02 | 1.454 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.796822e-02 | 1.421 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.461651e-02 | 1.461 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.517169e-02 | 1.454 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.984498e-02 | 1.400 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.984498e-02 | 1.400 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.037818e-02 | 1.394 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.085402e-02 | 1.389 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.189623e-02 | 1.378 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.270873e-02 | 1.369 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.297090e-02 | 1.367 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.396918e-02 | 1.357 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.418770e-02 | 1.355 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.620486e-02 | 1.335 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.685879e-02 | 1.329 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.685879e-02 | 1.329 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.712206e-02 | 1.327 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.924904e-02 | 1.308 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.041682e-02 | 1.297 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.215587e-02 | 1.283 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.222342e-02 | 1.282 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.330722e-02 | 1.273 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.413929e-02 | 1.266 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.432325e-02 | 1.265 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.187868e-02 | 1.208 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.187868e-02 | 1.208 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.269702e-02 | 1.203 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.269702e-02 | 1.203 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.247889e-02 | 1.204 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.038415e-02 | 1.219 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.960292e-02 | 1.225 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.247889e-02 | 1.204 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.974028e-02 | 1.224 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.974028e-02 | 1.224 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.161881e-02 | 1.210 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 6.187868e-02 | 1.208 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.583677e-02 | 1.253 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.367548e-02 | 1.196 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.974028e-02 | 1.224 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.974028e-02 | 1.224 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.032980e-02 | 1.219 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.438574e-02 | 1.191 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.438574e-02 | 1.191 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.581741e-02 | 1.182 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.640599e-02 | 1.178 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.780129e-02 | 1.169 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.780129e-02 | 1.169 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.780304e-02 | 1.169 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.794042e-02 | 1.168 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.984127e-02 | 1.156 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.083703e-02 | 1.150 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.123884e-02 | 1.147 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.138521e-02 | 1.146 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.138521e-02 | 1.146 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.138521e-02 | 1.146 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.138521e-02 | 1.146 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.138521e-02 | 1.146 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.237052e-02 | 1.140 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.460002e-02 | 1.127 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 7.460002e-02 | 1.127 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 7.460002e-02 | 1.127 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 8.839293e-02 | 1.054 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.839293e-02 | 1.054 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 8.839293e-02 | 1.054 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.427723e-02 | 1.074 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.427723e-02 | 1.074 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.427723e-02 | 1.074 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.631184e-02 | 1.117 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.631184e-02 | 1.117 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.187083e-02 | 1.087 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.404365e-02 | 1.075 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.291785e-02 | 1.081 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.228357e-02 | 1.085 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.228357e-02 | 1.085 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.228357e-02 | 1.085 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.483568e-02 | 1.126 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.873515e-02 | 1.104 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.363600e-02 | 1.078 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.291785e-02 | 1.081 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.170409e-02 | 1.088 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.105238e-02 | 1.091 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.936082e-02 | 1.100 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.396912e-02 | 1.131 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.629602e-02 | 1.064 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.443620e-02 | 1.128 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.614976e-02 | 1.118 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.170409e-02 | 1.088 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.774155e-02 | 1.109 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.848761e-02 | 1.105 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.427723e-02 | 1.074 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.102788e-02 | 1.041 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 9.385361e-02 | 1.028 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.385361e-02 | 1.028 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 9.385361e-02 | 1.028 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 9.385361e-02 | 1.028 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 9.385361e-02 | 1.028 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 9.385361e-02 | 1.028 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 9.385361e-02 | 1.028 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.663994e-02 | 1.015 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.663994e-02 | 1.015 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.861670e-02 | 1.006 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.038312e-01 | 0.984 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.038312e-01 | 0.984 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.044265e-01 | 0.981 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.059298e-01 | 0.975 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.206228e-01 | 0.919 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.206228e-01 | 0.919 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.206228e-01 | 0.919 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.206228e-01 | 0.919 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.188093e-01 | 0.925 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.188093e-01 | 0.925 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.188093e-01 | 0.925 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.188093e-01 | 0.925 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.067936e-01 | 0.971 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.067936e-01 | 0.971 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.067936e-01 | 0.971 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.067936e-01 | 0.971 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.132626e-01 | 0.946 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.144580e-01 | 0.941 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.247672e-01 | 0.904 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.094864e-01 | 0.961 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.273362e-01 | 0.895 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.227211e-01 | 0.911 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.227211e-01 | 0.911 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.211668e-01 | 0.917 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.317083e-01 | 0.880 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.328665e-01 | 0.877 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.168172e-01 | 0.932 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.240563e-01 | 0.906 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.197836e-01 | 0.922 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.132626e-01 | 0.946 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.067936e-01 | 0.971 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.210851e-01 | 0.917 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.144580e-01 | 0.941 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.240499e-01 | 0.906 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.067936e-01 | 0.971 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.132626e-01 | 0.946 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.328665e-01 | 0.877 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.102017e-01 | 0.958 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.222587e-01 | 0.913 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.091535e-01 | 0.962 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.328665e-01 | 0.877 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.172523e-01 | 0.931 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.117166e-01 | 0.952 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.105743e-01 | 0.956 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.317083e-01 | 0.880 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.144580e-01 | 0.941 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.306185e-01 | 0.884 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.074839e-01 | 0.969 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.317083e-01 | 0.880 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.293029e-01 | 0.888 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.297289e-01 | 0.887 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.067936e-01 | 0.971 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.297289e-01 | 0.887 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.328665e-01 | 0.877 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.333428e-01 | 0.875 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.344241e-01 | 0.872 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.344241e-01 | 0.872 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.344241e-01 | 0.872 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.368676e-01 | 0.864 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.377093e-01 | 0.861 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.384698e-01 | 0.859 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.384698e-01 | 0.859 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.384698e-01 | 0.859 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.384698e-01 | 0.859 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.402841e-01 | 0.853 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.402841e-01 | 0.853 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.407637e-01 | 0.852 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.407637e-01 | 0.852 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.716464e-01 | 0.765 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.716464e-01 | 0.765 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.887090e-01 | 0.724 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.887090e-01 | 0.724 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.887090e-01 | 0.724 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.887090e-01 | 0.724 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.587510e-01 | 0.799 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.587510e-01 | 0.799 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.587510e-01 | 0.799 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.587510e-01 | 0.799 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.587510e-01 | 0.799 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.876232e-01 | 0.727 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.571964e-01 | 0.804 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.814170e-01 | 0.741 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.814170e-01 | 0.741 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.814170e-01 | 0.741 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.466815e-01 | 0.834 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.485666e-01 | 0.828 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.740009e-01 | 0.759 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.740009e-01 | 0.759 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.548961e-01 | 0.810 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.697056e-01 | 0.770 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.697056e-01 | 0.770 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.697056e-01 | 0.770 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.732116e-01 | 0.761 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.587179e-01 | 0.799 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.542081e-01 | 0.812 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.633447e-01 | 0.787 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.814170e-01 | 0.741 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.450978e-01 | 0.838 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.876232e-01 | 0.727 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.436606e-01 | 0.843 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.456805e-01 | 0.837 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.705620e-01 | 0.768 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.804498e-01 | 0.744 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.525805e-01 | 0.817 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.542514e-01 | 0.812 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.876232e-01 | 0.727 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.876232e-01 | 0.727 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.571964e-01 | 0.804 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.567116e-01 | 0.805 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.697056e-01 | 0.770 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.587179e-01 | 0.799 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.641395e-01 | 0.785 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.539614e-01 | 0.813 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.452174e-01 | 0.838 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.456805e-01 | 0.837 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.452174e-01 | 0.838 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.452174e-01 | 0.838 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.804498e-01 | 0.744 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.876232e-01 | 0.727 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.735024e-01 | 0.761 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.470251e-01 | 0.833 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.455068e-01 | 0.837 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.716464e-01 | 0.765 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.885967e-01 | 0.724 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.823252e-01 | 0.739 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.664274e-01 | 0.779 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.876232e-01 | 0.727 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.571964e-01 | 0.804 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.567116e-01 | 0.805 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.887090e-01 | 0.724 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.876232e-01 | 0.727 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.876232e-01 | 0.727 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.571964e-01 | 0.804 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.851602e-01 | 0.732 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.650985e-01 | 0.782 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 1.587510e-01 | 0.799 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.450978e-01 | 0.838 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.829701e-01 | 0.738 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.723410e-01 | 0.764 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.898525e-01 | 0.722 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.920964e-01 | 0.716 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.920964e-01 | 0.716 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.922945e-01 | 0.716 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.922945e-01 | 0.716 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.922945e-01 | 0.716 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.928146e-01 | 0.715 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.938527e-01 | 0.713 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.955216e-01 | 0.709 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.577726e-01 | 0.589 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.577726e-01 | 0.589 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.577726e-01 | 0.589 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.577726e-01 | 0.589 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.577726e-01 | 0.589 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.577726e-01 | 0.589 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.254047e-01 | 0.647 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.254047e-01 | 0.647 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.254047e-01 | 0.647 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.254047e-01 | 0.647 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.605605e-01 | 0.443 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.605605e-01 | 0.443 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.605605e-01 | 0.443 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.605605e-01 | 0.443 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.605605e-01 | 0.443 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.605605e-01 | 0.443 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.605605e-01 | 0.443 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.605605e-01 | 0.443 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.605605e-01 | 0.443 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 3.605605e-01 | 0.443 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.605605e-01 | 0.443 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.605605e-01 | 0.443 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.605605e-01 | 0.443 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.605605e-01 | 0.443 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.605605e-01 | 0.443 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.605605e-01 | 0.443 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.801629e-01 | 0.553 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.801629e-01 | 0.553 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.801629e-01 | 0.553 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.268517e-01 | 0.644 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.268517e-01 | 0.644 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.268517e-01 | 0.644 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.268517e-01 | 0.644 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.180110e-01 | 0.662 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.180110e-01 | 0.662 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.662767e-01 | 0.575 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.662767e-01 | 0.575 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.662767e-01 | 0.575 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.662767e-01 | 0.575 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.346141e-01 | 0.475 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.346141e-01 | 0.475 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.346141e-01 | 0.475 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.346141e-01 | 0.475 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.346141e-01 | 0.475 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.346141e-01 | 0.475 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.346141e-01 | 0.475 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.491189e-01 | 0.348 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.491189e-01 | 0.348 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.491189e-01 | 0.348 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.491189e-01 | 0.348 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.069081e-01 | 0.684 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.069081e-01 | 0.684 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.069081e-01 | 0.684 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.495960e-01 | 0.603 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.495960e-01 | 0.603 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.064128e-01 | 0.514 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.064128e-01 | 0.514 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.064128e-01 | 0.514 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.064128e-01 | 0.514 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.064128e-01 | 0.514 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.064128e-01 | 0.514 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.877934e-01 | 0.411 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.877934e-01 | 0.411 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.877934e-01 | 0.411 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.877934e-01 | 0.411 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.877934e-01 | 0.411 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.609451e-01 | 0.583 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.467508e-01 | 0.460 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.151164e-01 | 0.502 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.151164e-01 | 0.502 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.151164e-01 | 0.502 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.891038e-01 | 0.539 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.304534e-01 | 0.637 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.304534e-01 | 0.637 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.178559e-01 | 0.662 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.699674e-01 | 0.569 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.177669e-01 | 0.498 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.484664e-01 | 0.458 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.484664e-01 | 0.458 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.868474e-01 | 0.412 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.868474e-01 | 0.412 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.390094e-01 | 0.358 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.390094e-01 | 0.358 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.390094e-01 | 0.358 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.390094e-01 | 0.358 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.390094e-01 | 0.358 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.390094e-01 | 0.358 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.390094e-01 | 0.358 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.390094e-01 | 0.358 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.390094e-01 | 0.358 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.254169e-01 | 0.279 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.254169e-01 | 0.279 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.254169e-01 | 0.279 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.254169e-01 | 0.279 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.254169e-01 | 0.279 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.254169e-01 | 0.279 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.254169e-01 | 0.279 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.254169e-01 | 0.279 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 5.254169e-01 | 0.279 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.254169e-01 | 0.279 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.254169e-01 | 0.279 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.254169e-01 | 0.279 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.254169e-01 | 0.279 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.923433e-01 | 0.534 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.707215e-01 | 0.567 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.263255e-01 | 0.370 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.138324e-01 | 0.503 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.494666e-01 | 0.603 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.696988e-01 | 0.432 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.696988e-01 | 0.432 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.696988e-01 | 0.432 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.150366e-01 | 0.382 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.150366e-01 | 0.382 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.877860e-01 | 0.312 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.877860e-01 | 0.312 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.877860e-01 | 0.312 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.877860e-01 | 0.312 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.877860e-01 | 0.312 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.047053e-01 | 0.516 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.425171e-01 | 0.615 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.958728e-01 | 0.402 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.958728e-01 | 0.402 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.958728e-01 | 0.402 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.958728e-01 | 0.402 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.958728e-01 | 0.402 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.648710e-01 | 0.333 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.875253e-01 | 0.412 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.797896e-01 | 0.420 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.478059e-01 | 0.349 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.339008e-01 | 0.363 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.079014e-01 | 0.512 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.219970e-01 | 0.375 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.479620e-01 | 0.349 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.479620e-01 | 0.349 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.625081e-01 | 0.335 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.625081e-01 | 0.335 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.625081e-01 | 0.335 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.799739e-01 | 0.319 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.799739e-01 | 0.319 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.022295e-01 | 0.299 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.338166e-01 | 0.273 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.338166e-01 | 0.273 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.911512e-01 | 0.228 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.911512e-01 | 0.228 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.911512e-01 | 0.228 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.911512e-01 | 0.228 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.911512e-01 | 0.228 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.911512e-01 | 0.228 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.113800e-01 | 0.291 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.129530e-01 | 0.384 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.350706e-01 | 0.361 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.382010e-01 | 0.269 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.382010e-01 | 0.269 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.382010e-01 | 0.269 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.382010e-01 | 0.269 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.382010e-01 | 0.269 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.418891e-01 | 0.266 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.769263e-01 | 0.239 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.769263e-01 | 0.239 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.627170e-01 | 0.335 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.170264e-01 | 0.286 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.452306e-01 | 0.263 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.452306e-01 | 0.263 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.330848e-01 | 0.273 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.330848e-01 | 0.273 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.330848e-01 | 0.273 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.330848e-01 | 0.273 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.800761e-01 | 0.319 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.483297e-01 | 0.261 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.512384e-01 | 0.259 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.713899e-01 | 0.243 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.713899e-01 | 0.243 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.566070e-01 | 0.254 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.526484e-01 | 0.258 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.714440e-01 | 0.243 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.721506e-01 | 0.242 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.721506e-01 | 0.242 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.880923e-01 | 0.540 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.219970e-01 | 0.375 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.479620e-01 | 0.349 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.736663e-01 | 0.325 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.322130e-01 | 0.634 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.306169e-01 | 0.366 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.622573e-01 | 0.335 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.507867e-01 | 0.601 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.322130e-01 | 0.634 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.012236e-01 | 0.696 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.038410e-01 | 0.691 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.819471e-01 | 0.550 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.478059e-01 | 0.349 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.891038e-01 | 0.539 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.792473e-01 | 0.554 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.239298e-01 | 0.281 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.330848e-01 | 0.273 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.049760e-01 | 0.393 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.902521e-01 | 0.310 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.279652e-01 | 0.484 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.648710e-01 | 0.333 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.826751e-01 | 0.316 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.773699e-01 | 0.239 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.114888e-01 | 0.386 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.321023e-01 | 0.274 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.435919e-01 | 0.464 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.507867e-01 | 0.601 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.150366e-01 | 0.382 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.113800e-01 | 0.291 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.714440e-01 | 0.243 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.822364e-01 | 0.235 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.662767e-01 | 0.575 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.069081e-01 | 0.684 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.696988e-01 | 0.432 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.150366e-01 | 0.382 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.526519e-01 | 0.597 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.526519e-01 | 0.597 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.452548e-01 | 0.462 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.316271e-01 | 0.635 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.726345e-01 | 0.242 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.635868e-01 | 0.439 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.195961e-01 | 0.658 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.463011e-01 | 0.461 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.463011e-01 | 0.461 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.064128e-01 | 0.514 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.467492e-01 | 0.460 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.405664e-01 | 0.619 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.799739e-01 | 0.319 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.113800e-01 | 0.291 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.566070e-01 | 0.254 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.552905e-01 | 0.255 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.356213e-01 | 0.474 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.215816e-01 | 0.493 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.979662e-01 | 0.526 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.064128e-01 | 0.514 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.595271e-01 | 0.586 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.022295e-01 | 0.299 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.968113e-01 | 0.304 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.769263e-01 | 0.239 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.026516e-01 | 0.299 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.176751e-01 | 0.498 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.216846e-01 | 0.493 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.254047e-01 | 0.647 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.346141e-01 | 0.475 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.064128e-01 | 0.514 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.390094e-01 | 0.358 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.150366e-01 | 0.382 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.877860e-01 | 0.312 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.972074e-01 | 0.705 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.769263e-01 | 0.239 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.512384e-01 | 0.259 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.512384e-01 | 0.259 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.239298e-01 | 0.281 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.877860e-01 | 0.312 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.484664e-01 | 0.458 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.215518e-01 | 0.655 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.354196e-01 | 0.474 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.268517e-01 | 0.644 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.609451e-01 | 0.583 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.109362e-01 | 0.676 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.484664e-01 | 0.458 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.390094e-01 | 0.358 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.263255e-01 | 0.370 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.527289e-01 | 0.597 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.478059e-01 | 0.349 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.037270e-01 | 0.518 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.732170e-01 | 0.242 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.141800e-01 | 0.669 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.494666e-01 | 0.603 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.194346e-01 | 0.659 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.409361e-01 | 0.467 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.182783e-01 | 0.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.268517e-01 | 0.644 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.064128e-01 | 0.514 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.263255e-01 | 0.370 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.219970e-01 | 0.375 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.022295e-01 | 0.299 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.396934e-01 | 0.357 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.024316e-01 | 0.694 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.763709e-01 | 0.322 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.409361e-01 | 0.467 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.789783e-01 | 0.421 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.036330e-01 | 0.394 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.152349e-01 | 0.382 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.382671e-01 | 0.358 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.789783e-01 | 0.421 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.928567e-01 | 0.533 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.723981e-01 | 0.565 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.662767e-01 | 0.575 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.491189e-01 | 0.348 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.495960e-01 | 0.603 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.877934e-01 | 0.411 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.868474e-01 | 0.412 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.390094e-01 | 0.358 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.877860e-01 | 0.312 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.877860e-01 | 0.312 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.635868e-01 | 0.439 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.142352e-01 | 0.503 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.022295e-01 | 0.299 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.338166e-01 | 0.273 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.736663e-01 | 0.325 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.557530e-01 | 0.341 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.872498e-01 | 0.312 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.858602e-01 | 0.232 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.951169e-01 | 0.403 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.479348e-01 | 0.606 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.844647e-01 | 0.315 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.505768e-01 | 0.601 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.928567e-01 | 0.533 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.818525e-01 | 0.418 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.612435e-01 | 0.336 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.567421e-01 | 0.591 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.819872e-01 | 0.235 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.454295e-01 | 0.610 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.549378e-01 | 0.342 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.195961e-01 | 0.658 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.799660e-01 | 0.553 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.423641e-01 | 0.616 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.561009e-01 | 0.341 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.799114e-01 | 0.237 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.512384e-01 | 0.259 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.141902e-01 | 0.383 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.141902e-01 | 0.383 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.180110e-01 | 0.662 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.495960e-01 | 0.603 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.064128e-01 | 0.514 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.151164e-01 | 0.502 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.210005e-01 | 0.656 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.215816e-01 | 0.493 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.382010e-01 | 0.269 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.239298e-01 | 0.281 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.726345e-01 | 0.242 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.232749e-01 | 0.490 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.802440e-01 | 0.420 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.431520e-01 | 0.265 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.877934e-01 | 0.411 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.965215e-01 | 0.402 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.533166e-01 | 0.452 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.474115e-01 | 0.459 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.365502e-01 | 0.270 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.151164e-01 | 0.502 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.773699e-01 | 0.239 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.675182e-01 | 0.246 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.436108e-01 | 0.265 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.110355e-01 | 0.507 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.065324e-01 | 0.685 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.605605e-01 | 0.443 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.268517e-01 | 0.644 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.662767e-01 | 0.575 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.346141e-01 | 0.475 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.491189e-01 | 0.348 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.491189e-01 | 0.348 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.491189e-01 | 0.348 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.467508e-01 | 0.460 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.467508e-01 | 0.460 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.974530e-01 | 0.705 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.526519e-01 | 0.597 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.356213e-01 | 0.474 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.356213e-01 | 0.474 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.877860e-01 | 0.312 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.047053e-01 | 0.516 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.875047e-01 | 0.541 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.811464e-01 | 0.419 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.479620e-01 | 0.349 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.906715e-01 | 0.309 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.684266e-01 | 0.329 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.182783e-01 | 0.285 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.182783e-01 | 0.285 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.831754e-01 | 0.316 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.418891e-01 | 0.266 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.713899e-01 | 0.243 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.074633e-01 | 0.683 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.945559e-01 | 0.531 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.532182e-01 | 0.452 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.493945e-01 | 0.347 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.330848e-01 | 0.273 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.176751e-01 | 0.498 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.662101e-01 | 0.575 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.662101e-01 | 0.575 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.844482e-01 | 0.546 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.958728e-01 | 0.402 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.648710e-01 | 0.333 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.206735e-01 | 0.376 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.039340e-01 | 0.691 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.258163e-01 | 0.646 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 4.390094e-01 | 0.358 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.712323e-01 | 0.567 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.338166e-01 | 0.273 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.467508e-01 | 0.460 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.494666e-01 | 0.603 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.169540e-01 | 0.499 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.911512e-01 | 0.228 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.290122e-01 | 0.483 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.518683e-01 | 0.454 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.357369e-01 | 0.474 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.662767e-01 | 0.575 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.669283e-01 | 0.574 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.505768e-01 | 0.601 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.390094e-01 | 0.358 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.022295e-01 | 0.299 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.173499e-01 | 0.498 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.113800e-01 | 0.291 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.539896e-01 | 0.256 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.865647e-01 | 0.232 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.211702e-01 | 0.493 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.648710e-01 | 0.333 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.745809e-01 | 0.561 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.593289e-01 | 0.445 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.736663e-01 | 0.325 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.951145e-01 | 0.305 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.684266e-01 | 0.329 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.002232e-01 | 0.301 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.113800e-01 | 0.291 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.263255e-01 | 0.370 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.819471e-01 | 0.550 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.346141e-01 | 0.475 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.491189e-01 | 0.348 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.064128e-01 | 0.514 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.467508e-01 | 0.460 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.151164e-01 | 0.502 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.699674e-01 | 0.569 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.521107e-01 | 0.598 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.648710e-01 | 0.333 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.338166e-01 | 0.273 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.911512e-01 | 0.228 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.911512e-01 | 0.228 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.059108e-01 | 0.296 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 5.769263e-01 | 0.239 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.769263e-01 | 0.239 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.924942e-01 | 0.308 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.726345e-01 | 0.242 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.366762e-01 | 0.360 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.488600e-01 | 0.261 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.268517e-01 | 0.644 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.425171e-01 | 0.615 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.467492e-01 | 0.460 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.185179e-01 | 0.661 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.254169e-01 | 0.279 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.287852e-01 | 0.277 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.301185e-01 | 0.276 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.491189e-01 | 0.348 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.390094e-01 | 0.358 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.877860e-01 | 0.312 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.020181e-01 | 0.396 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.242459e-01 | 0.372 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.911512e-01 | 0.228 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.769263e-01 | 0.239 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.334993e-01 | 0.273 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.895201e-01 | 0.310 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.177669e-01 | 0.498 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.182783e-01 | 0.285 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.827558e-01 | 0.549 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.611891e-01 | 0.442 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.114888e-01 | 0.386 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.064128e-01 | 0.514 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.801629e-01 | 0.553 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.346141e-01 | 0.475 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.390094e-01 | 0.358 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.263255e-01 | 0.370 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.338166e-01 | 0.273 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.721506e-01 | 0.242 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.721506e-01 | 0.242 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.461893e-01 | 0.461 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.373660e-01 | 0.359 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.764787e-01 | 0.558 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.946736e-01 | 0.226 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.946736e-01 | 0.226 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.946736e-01 | 0.226 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.946736e-01 | 0.226 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.952947e-01 | 0.225 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.953351e-01 | 0.225 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.953351e-01 | 0.225 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.968478e-01 | 0.224 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.968478e-01 | 0.224 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.968478e-01 | 0.224 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.968478e-01 | 0.224 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.997937e-01 | 0.222 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.997937e-01 | 0.222 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.997937e-01 | 0.222 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.997937e-01 | 0.222 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.997937e-01 | 0.222 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.041083e-01 | 0.219 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.054222e-01 | 0.218 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.054222e-01 | 0.218 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.054222e-01 | 0.218 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.054222e-01 | 0.218 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.054222e-01 | 0.218 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.054222e-01 | 0.218 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.054222e-01 | 0.218 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.087350e-01 | 0.216 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.127265e-01 | 0.213 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.132905e-01 | 0.212 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.132905e-01 | 0.212 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.170411e-01 | 0.210 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.170411e-01 | 0.210 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.170411e-01 | 0.210 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.170411e-01 | 0.210 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.170411e-01 | 0.210 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.170411e-01 | 0.210 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.170411e-01 | 0.210 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 6.170411e-01 | 0.210 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.170411e-01 | 0.210 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.178346e-01 | 0.209 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.178346e-01 | 0.209 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.178346e-01 | 0.209 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.178346e-01 | 0.209 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.194124e-01 | 0.208 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.213842e-01 | 0.207 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.213842e-01 | 0.207 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.259463e-01 | 0.203 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.270327e-01 | 0.203 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.270327e-01 | 0.203 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.270327e-01 | 0.203 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.282455e-01 | 0.202 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.291364e-01 | 0.201 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.300296e-01 | 0.201 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.310920e-01 | 0.200 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.313428e-01 | 0.200 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.324036e-01 | 0.199 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.332168e-01 | 0.198 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.358621e-01 | 0.197 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.364939e-01 | 0.196 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.364939e-01 | 0.196 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.364939e-01 | 0.196 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.417809e-01 | 0.193 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.449657e-01 | 0.190 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.450073e-01 | 0.190 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.451812e-01 | 0.190 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.477840e-01 | 0.189 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.477840e-01 | 0.189 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.477840e-01 | 0.189 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.477840e-01 | 0.189 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.477840e-01 | 0.189 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.477840e-01 | 0.189 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.477840e-01 | 0.189 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.477840e-01 | 0.189 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.477840e-01 | 0.189 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.477840e-01 | 0.189 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.477840e-01 | 0.189 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.477840e-01 | 0.189 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.477840e-01 | 0.189 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.477840e-01 | 0.189 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.477840e-01 | 0.189 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.477840e-01 | 0.189 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.477840e-01 | 0.189 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.489318e-01 | 0.188 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.517604e-01 | 0.186 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.530582e-01 | 0.185 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.530582e-01 | 0.185 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.530582e-01 | 0.185 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.530582e-01 | 0.185 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.530582e-01 | 0.185 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.540869e-01 | 0.184 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.541635e-01 | 0.184 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.541635e-01 | 0.184 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.541635e-01 | 0.184 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.541635e-01 | 0.184 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.541635e-01 | 0.184 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.541635e-01 | 0.184 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.541635e-01 | 0.184 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.541635e-01 | 0.184 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.541635e-01 | 0.184 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.541635e-01 | 0.184 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.541635e-01 | 0.184 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.590359e-01 | 0.181 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.606251e-01 | 0.180 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.653292e-01 | 0.177 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.658119e-01 | 0.177 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.658119e-01 | 0.177 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.658119e-01 | 0.177 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.658119e-01 | 0.177 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.660373e-01 | 0.177 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.676829e-01 | 0.175 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.679104e-01 | 0.175 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.697481e-01 | 0.174 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.697481e-01 | 0.174 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.745454e-01 | 0.171 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.778381e-01 | 0.169 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.778381e-01 | 0.169 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.778381e-01 | 0.169 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.778381e-01 | 0.169 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.778381e-01 | 0.169 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.778381e-01 | 0.169 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.778381e-01 | 0.169 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.805780e-01 | 0.167 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.808587e-01 | 0.167 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.826425e-01 | 0.166 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.871620e-01 | 0.163 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.883528e-01 | 0.162 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.883528e-01 | 0.162 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.883528e-01 | 0.162 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.883528e-01 | 0.162 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.883528e-01 | 0.162 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.883528e-01 | 0.162 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.883528e-01 | 0.162 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.883528e-01 | 0.162 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.883528e-01 | 0.162 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.883528e-01 | 0.162 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.883528e-01 | 0.162 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.883528e-01 | 0.162 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.883528e-01 | 0.162 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.928911e-01 | 0.159 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.928911e-01 | 0.159 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.928911e-01 | 0.159 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.933656e-01 | 0.159 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.933656e-01 | 0.159 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.933656e-01 | 0.159 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.933656e-01 | 0.159 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.933656e-01 | 0.159 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.960426e-01 | 0.157 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.965750e-01 | 0.157 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.965750e-01 | 0.157 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.965750e-01 | 0.157 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.965750e-01 | 0.157 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.965750e-01 | 0.157 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.965750e-01 | 0.157 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.965750e-01 | 0.157 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.965750e-01 | 0.157 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.965750e-01 | 0.157 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.965750e-01 | 0.157 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.965750e-01 | 0.157 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.965750e-01 | 0.157 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.965750e-01 | 0.157 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.965750e-01 | 0.157 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.965750e-01 | 0.157 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.965750e-01 | 0.157 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.965750e-01 | 0.157 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.965750e-01 | 0.157 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.965750e-01 | 0.157 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.965750e-01 | 0.157 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.965750e-01 | 0.157 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.965750e-01 | 0.157 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.965750e-01 | 0.157 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.965750e-01 | 0.157 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.965750e-01 | 0.157 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.987335e-01 | 0.156 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.002916e-01 | 0.155 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.002916e-01 | 0.155 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.002916e-01 | 0.155 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.013560e-01 | 0.154 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.013560e-01 | 0.154 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.013560e-01 | 0.154 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.013560e-01 | 0.154 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.039880e-01 | 0.152 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.039880e-01 | 0.152 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.054056e-01 | 0.152 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.060249e-01 | 0.151 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.068342e-01 | 0.151 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.101044e-01 | 0.149 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.101044e-01 | 0.149 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.105532e-01 | 0.148 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.142994e-01 | 0.146 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.155909e-01 | 0.145 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.191672e-01 | 0.143 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.197092e-01 | 0.143 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.197092e-01 | 0.143 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.197092e-01 | 0.143 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.197092e-01 | 0.143 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.197092e-01 | 0.143 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.197092e-01 | 0.143 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.197092e-01 | 0.143 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.197092e-01 | 0.143 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.197092e-01 | 0.143 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.197092e-01 | 0.143 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.197092e-01 | 0.143 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.197092e-01 | 0.143 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.197092e-01 | 0.143 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.197092e-01 | 0.143 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.197092e-01 | 0.143 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.202158e-01 | 0.143 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.236085e-01 | 0.140 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.236085e-01 | 0.140 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.236085e-01 | 0.140 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.236085e-01 | 0.140 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.275224e-01 | 0.138 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.275224e-01 | 0.138 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.293325e-01 | 0.137 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.298297e-01 | 0.137 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.298297e-01 | 0.137 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.298297e-01 | 0.137 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.298297e-01 | 0.137 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.358383e-01 | 0.133 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.358383e-01 | 0.133 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.358383e-01 | 0.133 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.367144e-01 | 0.133 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.379545e-01 | 0.132 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.379545e-01 | 0.132 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.379545e-01 | 0.132 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.386095e-01 | 0.132 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.386095e-01 | 0.132 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.386095e-01 | 0.132 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.386095e-01 | 0.132 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.386095e-01 | 0.132 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.386095e-01 | 0.132 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.391154e-01 | 0.131 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.425606e-01 | 0.129 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.425606e-01 | 0.129 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.432474e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.432474e-01 | 0.129 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.432474e-01 | 0.129 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.432474e-01 | 0.129 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.432474e-01 | 0.129 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.432474e-01 | 0.129 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.432474e-01 | 0.129 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.437943e-01 | 0.129 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.446036e-01 | 0.128 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.458569e-01 | 0.127 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.483614e-01 | 0.126 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.483614e-01 | 0.126 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.483614e-01 | 0.126 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.483614e-01 | 0.126 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.483614e-01 | 0.126 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.483614e-01 | 0.126 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.483614e-01 | 0.126 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.483614e-01 | 0.126 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.483614e-01 | 0.126 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.483614e-01 | 0.126 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.514860e-01 | 0.124 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.536982e-01 | 0.123 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.602222e-01 | 0.119 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.635572e-01 | 0.117 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.643593e-01 | 0.117 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.645304e-01 | 0.117 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.652562e-01 | 0.116 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.652562e-01 | 0.116 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.656518e-01 | 0.116 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.656518e-01 | 0.116 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.656518e-01 | 0.116 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.656518e-01 | 0.116 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.663167e-01 | 0.116 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.663167e-01 | 0.116 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.744566e-01 | 0.111 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.744566e-01 | 0.111 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.744566e-01 | 0.111 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.744566e-01 | 0.111 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.744566e-01 | 0.111 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.744566e-01 | 0.111 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.744566e-01 | 0.111 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.744566e-01 | 0.111 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.744566e-01 | 0.111 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.748230e-01 | 0.111 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.748230e-01 | 0.111 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.748230e-01 | 0.111 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.748230e-01 | 0.111 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.748230e-01 | 0.111 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.748230e-01 | 0.111 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.748230e-01 | 0.111 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.748230e-01 | 0.111 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.748230e-01 | 0.111 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.748230e-01 | 0.111 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.748230e-01 | 0.111 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.748230e-01 | 0.111 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.748230e-01 | 0.111 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.748230e-01 | 0.111 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.769697e-01 | 0.110 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.769697e-01 | 0.110 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.790530e-01 | 0.108 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.840675e-01 | 0.106 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.850463e-01 | 0.105 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.852326e-01 | 0.105 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.852326e-01 | 0.105 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.864374e-01 | 0.104 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.864374e-01 | 0.104 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.864374e-01 | 0.104 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.877028e-01 | 0.104 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.884347e-01 | 0.103 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.891599e-01 | 0.103 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.891599e-01 | 0.103 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.922469e-01 | 0.101 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.922469e-01 | 0.101 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.922469e-01 | 0.101 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.922469e-01 | 0.101 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.922469e-01 | 0.101 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.964297e-01 | 0.099 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.981534e-01 | 0.098 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.981534e-01 | 0.098 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.981534e-01 | 0.098 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 7.981534e-01 | 0.098 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.981534e-01 | 0.098 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.981534e-01 | 0.098 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.981534e-01 | 0.098 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.981534e-01 | 0.098 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.981534e-01 | 0.098 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.981534e-01 | 0.098 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.992928e-01 | 0.097 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.998043e-01 | 0.097 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.998043e-01 | 0.097 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.002641e-01 | 0.097 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.042544e-01 | 0.095 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.051808e-01 | 0.094 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.056700e-01 | 0.094 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.056700e-01 | 0.094 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.056700e-01 | 0.094 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.056700e-01 | 0.094 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.060212e-01 | 0.094 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 8.060212e-01 | 0.094 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.060212e-01 | 0.094 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.060212e-01 | 0.094 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 8.060212e-01 | 0.094 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.060212e-01 | 0.094 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.060212e-01 | 0.094 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.060212e-01 | 0.094 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.060212e-01 | 0.094 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.060212e-01 | 0.094 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.060212e-01 | 0.094 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.060212e-01 | 0.094 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.060212e-01 | 0.094 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.135989e-01 | 0.090 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.136530e-01 | 0.090 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.138448e-01 | 0.089 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.138448e-01 | 0.089 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.138448e-01 | 0.089 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.164845e-01 | 0.088 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.196153e-01 | 0.086 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.196153e-01 | 0.086 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.196153e-01 | 0.086 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.196153e-01 | 0.086 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.196153e-01 | 0.086 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 8.234217e-01 | 0.084 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.234217e-01 | 0.084 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.234217e-01 | 0.084 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.234217e-01 | 0.084 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.266349e-01 | 0.083 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.269659e-01 | 0.083 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.278551e-01 | 0.082 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.278551e-01 | 0.082 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.311410e-01 | 0.080 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.311410e-01 | 0.080 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.311410e-01 | 0.080 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.328984e-01 | 0.079 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.328984e-01 | 0.079 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.328984e-01 | 0.079 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.328984e-01 | 0.079 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.328984e-01 | 0.079 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.328984e-01 | 0.079 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.328984e-01 | 0.079 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.328984e-01 | 0.079 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.328984e-01 | 0.079 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.328984e-01 | 0.079 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.389331e-01 | 0.076 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.390066e-01 | 0.076 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.390066e-01 | 0.076 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.390066e-01 | 0.076 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.390066e-01 | 0.076 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.390066e-01 | 0.076 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.390066e-01 | 0.076 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.397686e-01 | 0.076 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.397686e-01 | 0.076 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.397686e-01 | 0.076 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.397686e-01 | 0.076 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.397686e-01 | 0.076 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.397686e-01 | 0.076 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.406724e-01 | 0.075 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.409963e-01 | 0.075 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.409963e-01 | 0.075 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.409963e-01 | 0.075 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.456733e-01 | 0.073 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.456733e-01 | 0.073 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.500449e-01 | 0.071 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.505165e-01 | 0.070 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.533003e-01 | 0.069 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.533003e-01 | 0.069 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.533003e-01 | 0.069 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.547895e-01 | 0.068 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.547895e-01 | 0.068 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.547895e-01 | 0.068 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.560529e-01 | 0.067 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.560529e-01 | 0.067 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.560529e-01 | 0.067 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.560529e-01 | 0.067 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.560529e-01 | 0.067 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.560529e-01 | 0.067 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.560529e-01 | 0.067 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.560529e-01 | 0.067 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.560529e-01 | 0.067 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.560529e-01 | 0.067 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.560529e-01 | 0.067 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.560529e-01 | 0.067 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.560529e-01 | 0.067 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.560529e-01 | 0.067 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.560529e-01 | 0.067 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.564890e-01 | 0.067 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.564890e-01 | 0.067 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.564890e-01 | 0.067 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.564890e-01 | 0.067 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.564890e-01 | 0.067 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.564890e-01 | 0.067 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.564890e-01 | 0.067 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.587357e-01 | 0.066 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.587357e-01 | 0.066 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.587357e-01 | 0.066 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.614093e-01 | 0.065 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.625396e-01 | 0.064 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.648008e-01 | 0.063 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.650624e-01 | 0.063 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.684249e-01 | 0.061 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.685640e-01 | 0.061 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.685640e-01 | 0.061 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.685640e-01 | 0.061 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.694819e-01 | 0.061 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.708424e-01 | 0.060 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.708424e-01 | 0.060 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.722190e-01 | 0.059 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.722190e-01 | 0.059 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.760002e-01 | 0.057 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.760002e-01 | 0.057 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.760002e-01 | 0.057 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.760002e-01 | 0.057 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.760002e-01 | 0.057 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.760002e-01 | 0.057 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.760002e-01 | 0.057 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.760002e-01 | 0.057 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.760002e-01 | 0.057 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.760002e-01 | 0.057 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.760002e-01 | 0.057 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.767950e-01 | 0.057 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.786513e-01 | 0.056 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.811714e-01 | 0.055 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.811714e-01 | 0.055 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.812266e-01 | 0.055 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.812385e-01 | 0.055 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.820436e-01 | 0.055 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.820436e-01 | 0.055 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.820436e-01 | 0.055 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.855312e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.855353e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.863466e-01 | 0.052 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.863466e-01 | 0.052 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.863466e-01 | 0.052 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.863466e-01 | 0.052 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.876569e-01 | 0.052 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.902047e-01 | 0.051 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.907790e-01 | 0.050 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.923897e-01 | 0.049 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.923897e-01 | 0.049 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.926900e-01 | 0.049 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.926900e-01 | 0.049 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.931843e-01 | 0.049 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.931843e-01 | 0.049 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.931843e-01 | 0.049 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.931843e-01 | 0.049 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.948328e-01 | 0.048 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.948328e-01 | 0.048 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.953841e-01 | 0.048 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.953841e-01 | 0.048 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.990137e-01 | 0.046 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.990137e-01 | 0.046 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.990137e-01 | 0.046 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.990137e-01 | 0.046 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.990137e-01 | 0.046 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.019309e-01 | 0.045 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.019309e-01 | 0.045 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.019309e-01 | 0.045 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.031960e-01 | 0.044 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.031960e-01 | 0.044 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.031960e-01 | 0.044 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.031960e-01 | 0.044 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.034731e-01 | 0.044 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.034731e-01 | 0.044 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.038511e-01 | 0.044 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.054905e-01 | 0.043 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 9.079878e-01 | 0.042 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 9.079878e-01 | 0.042 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.079878e-01 | 0.042 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.079878e-01 | 0.042 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.079878e-01 | 0.042 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.079878e-01 | 0.042 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.079878e-01 | 0.042 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.079878e-01 | 0.042 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.079878e-01 | 0.042 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.079878e-01 | 0.042 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 9.079878e-01 | 0.042 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 9.079878e-01 | 0.042 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 9.079878e-01 | 0.042 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 9.079878e-01 | 0.042 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.079878e-01 | 0.042 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.099557e-01 | 0.041 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.103536e-01 | 0.041 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.103536e-01 | 0.041 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.103536e-01 | 0.041 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.103536e-01 | 0.041 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.114880e-01 | 0.040 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.114880e-01 | 0.040 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.127631e-01 | 0.040 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.137451e-01 | 0.039 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.141469e-01 | 0.039 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.145240e-01 | 0.039 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.167964e-01 | 0.038 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.187939e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.187939e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.187939e-01 | 0.037 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.189126e-01 | 0.037 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.204910e-01 | 0.036 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.204910e-01 | 0.036 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.204910e-01 | 0.036 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.204910e-01 | 0.036 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.204910e-01 | 0.036 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.204910e-01 | 0.036 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.204910e-01 | 0.036 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.204910e-01 | 0.036 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.207405e-01 | 0.036 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.207405e-01 | 0.036 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.207405e-01 | 0.036 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.207405e-01 | 0.036 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.207405e-01 | 0.036 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.207405e-01 | 0.036 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.207405e-01 | 0.036 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.219172e-01 | 0.035 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.224406e-01 | 0.035 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.257814e-01 | 0.033 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.262105e-01 | 0.033 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.262105e-01 | 0.033 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.262105e-01 | 0.033 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.262105e-01 | 0.033 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.268839e-01 | 0.033 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.293604e-01 | 0.032 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.293604e-01 | 0.032 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.293604e-01 | 0.032 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.295411e-01 | 0.032 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.313593e-01 | 0.031 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.317263e-01 | 0.031 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.317263e-01 | 0.031 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.317263e-01 | 0.031 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.317263e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.317263e-01 | 0.031 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.317263e-01 | 0.031 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.317263e-01 | 0.031 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.317263e-01 | 0.031 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 9.317263e-01 | 0.031 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 9.317263e-01 | 0.031 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 9.317263e-01 | 0.031 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.317263e-01 | 0.031 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.317263e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.317263e-01 | 0.031 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.317263e-01 | 0.031 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.317263e-01 | 0.031 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.317263e-01 | 0.031 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.317263e-01 | 0.031 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.317263e-01 | 0.031 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.327671e-01 | 0.030 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.330110e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.365220e-01 | 0.028 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.370244e-01 | 0.028 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.376107e-01 | 0.028 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.379849e-01 | 0.028 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.382270e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.387746e-01 | 0.027 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.392385e-01 | 0.027 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.392385e-01 | 0.027 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.408891e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.410897e-01 | 0.026 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.411294e-01 | 0.026 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.411899e-01 | 0.026 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.411899e-01 | 0.026 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.411899e-01 | 0.026 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.411899e-01 | 0.026 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.411899e-01 | 0.026 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.411899e-01 | 0.026 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.411899e-01 | 0.026 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.411899e-01 | 0.026 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.411899e-01 | 0.026 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.411899e-01 | 0.026 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.413435e-01 | 0.026 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.421168e-01 | 0.026 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.430072e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.430072e-01 | 0.025 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.430072e-01 | 0.025 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.430072e-01 | 0.025 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.432886e-01 | 0.025 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.433836e-01 | 0.025 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.433836e-01 | 0.025 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.433836e-01 | 0.025 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.433836e-01 | 0.025 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.445710e-01 | 0.025 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.449344e-01 | 0.025 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.449344e-01 | 0.025 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.449344e-01 | 0.025 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.453695e-01 | 0.024 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.453695e-01 | 0.024 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.454831e-01 | 0.024 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.457461e-01 | 0.024 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.479758e-01 | 0.023 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.479758e-01 | 0.023 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.483542e-01 | 0.023 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.484926e-01 | 0.023 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.493423e-01 | 0.023 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.493423e-01 | 0.023 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.493423e-01 | 0.023 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.493423e-01 | 0.023 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.493423e-01 | 0.023 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.493423e-01 | 0.023 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.493423e-01 | 0.023 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.493423e-01 | 0.023 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.493423e-01 | 0.023 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.495842e-01 | 0.022 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.495842e-01 | 0.022 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.511913e-01 | 0.022 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.511913e-01 | 0.022 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.512070e-01 | 0.022 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.529257e-01 | 0.021 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.541715e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.541715e-01 | 0.020 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.548859e-01 | 0.020 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.563649e-01 | 0.019 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.563649e-01 | 0.019 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.563649e-01 | 0.019 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.563649e-01 | 0.019 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.563649e-01 | 0.019 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.563649e-01 | 0.019 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.563649e-01 | 0.019 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.563649e-01 | 0.019 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.563649e-01 | 0.019 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.563649e-01 | 0.019 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.568738e-01 | 0.019 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.568738e-01 | 0.019 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.571256e-01 | 0.019 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.571256e-01 | 0.019 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.589530e-01 | 0.018 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.589530e-01 | 0.018 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.591987e-01 | 0.018 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.596385e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.598755e-01 | 0.018 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.602893e-01 | 0.018 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.602893e-01 | 0.018 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.619191e-01 | 0.017 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.619191e-01 | 0.017 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.624144e-01 | 0.017 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.624144e-01 | 0.017 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.624144e-01 | 0.017 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.624144e-01 | 0.017 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.624144e-01 | 0.017 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.624144e-01 | 0.017 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.624144e-01 | 0.017 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.630794e-01 | 0.016 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.645142e-01 | 0.016 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.659155e-01 | 0.015 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.663949e-01 | 0.015 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.663949e-01 | 0.015 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.663949e-01 | 0.015 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.663949e-01 | 0.015 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.667062e-01 | 0.015 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.671442e-01 | 0.015 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.676255e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.676255e-01 | 0.014 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.676255e-01 | 0.014 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.676255e-01 | 0.014 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.676255e-01 | 0.014 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.676255e-01 | 0.014 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.687104e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.689343e-01 | 0.014 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.692341e-01 | 0.014 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.692341e-01 | 0.014 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.697858e-01 | 0.013 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.703619e-01 | 0.013 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.706358e-01 | 0.013 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.706358e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.707133e-01 | 0.013 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.715114e-01 | 0.013 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.720445e-01 | 0.012 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.721143e-01 | 0.012 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.721143e-01 | 0.012 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.721143e-01 | 0.012 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.721143e-01 | 0.012 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.721143e-01 | 0.012 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.721143e-01 | 0.012 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.721143e-01 | 0.012 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.721143e-01 | 0.012 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.721143e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.721143e-01 | 0.012 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.734215e-01 | 0.012 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.734552e-01 | 0.012 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.735907e-01 | 0.012 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.737739e-01 | 0.012 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.738751e-01 | 0.011 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.738751e-01 | 0.011 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.738751e-01 | 0.011 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.738751e-01 | 0.011 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.745791e-01 | 0.011 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.746628e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.749596e-01 | 0.011 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.756353e-01 | 0.011 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.758953e-01 | 0.011 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.759810e-01 | 0.011 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.759810e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.759810e-01 | 0.011 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.759810e-01 | 0.011 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.759810e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.765918e-01 | 0.010 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.769842e-01 | 0.010 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.769842e-01 | 0.010 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.791200e-01 | 0.009 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.791200e-01 | 0.009 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.793117e-01 | 0.009 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.793117e-01 | 0.009 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.793117e-01 | 0.009 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.793117e-01 | 0.009 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.793117e-01 | 0.009 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.795656e-01 | 0.009 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.799145e-01 | 0.009 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.802666e-01 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.813865e-01 | 0.008 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.821633e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.821633e-01 | 0.008 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.821807e-01 | 0.008 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.821807e-01 | 0.008 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.821807e-01 | 0.008 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.821807e-01 | 0.008 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.821807e-01 | 0.008 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.821807e-01 | 0.008 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.822575e-01 | 0.008 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.825731e-01 | 0.008 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.825741e-01 | 0.008 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.830061e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.834166e-01 | 0.007 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.843090e-01 | 0.007 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.843090e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.843090e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.846520e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.846520e-01 | 0.007 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.846520e-01 | 0.007 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.846520e-01 | 0.007 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.846520e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.846520e-01 | 0.007 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.851757e-01 | 0.006 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.852337e-01 | 0.006 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.859669e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.859669e-01 | 0.006 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.859669e-01 | 0.006 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.862028e-01 | 0.006 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.862028e-01 | 0.006 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.862028e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.862028e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.862028e-01 | 0.006 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.862028e-01 | 0.006 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.867806e-01 | 0.006 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.867806e-01 | 0.006 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.867806e-01 | 0.006 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.867806e-01 | 0.006 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.867806e-01 | 0.006 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.867806e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.880771e-01 | 0.005 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.880783e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.880783e-01 | 0.005 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.883115e-01 | 0.005 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.884107e-01 | 0.005 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.884107e-01 | 0.005 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.886142e-01 | 0.005 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.886142e-01 | 0.005 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.886142e-01 | 0.005 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.886142e-01 | 0.005 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.893459e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.893459e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.893459e-01 | 0.005 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.896662e-01 | 0.005 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.901935e-01 | 0.004 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.901935e-01 | 0.004 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.901935e-01 | 0.004 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.901935e-01 | 0.004 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.901935e-01 | 0.004 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.901935e-01 | 0.004 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.901935e-01 | 0.004 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.901935e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.907404e-01 | 0.004 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.915538e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.915538e-01 | 0.004 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.915538e-01 | 0.004 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.915538e-01 | 0.004 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.915538e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.917860e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.917860e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.917860e-01 | 0.004 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.920313e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.927206e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.927255e-01 | 0.003 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.927255e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.927255e-01 | 0.003 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.927255e-01 | 0.003 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.927255e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.927255e-01 | 0.003 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.927255e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.927918e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.927918e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.929475e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.935354e-01 | 0.003 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.937347e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.942297e-01 | 0.003 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.942297e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.944548e-01 | 0.002 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.946040e-01 | 0.002 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.946040e-01 | 0.002 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.949504e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.951388e-01 | 0.002 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.951444e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.951612e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.952571e-01 | 0.002 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.953527e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.955744e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.958081e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.959975e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.959975e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.960137e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.962193e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.962677e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.962677e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.962677e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.964089e-01 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.964652e-01 | 0.002 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.966418e-01 | 0.001 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.967311e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.969658e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.969670e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.969914e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.970313e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.971378e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.973178e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.975554e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.976097e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.977641e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.977981e-01 | 0.001 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.977981e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.978387e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.978387e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.980502e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.980819e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.980819e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.981038e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.981040e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.983123e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.983493e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.983550e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.983670e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.983670e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.984300e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.985937e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.985937e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.985937e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.985951e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.987378e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.987889e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.988123e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.988791e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.989570e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.989657e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.989751e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.989751e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.991018e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.992265e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.992480e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.992689e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.992841e-01 | 0.000 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.992972e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.993060e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.993339e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.993339e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.993474e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.993491e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.993806e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994904e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.995061e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.995179e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.995659e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.995747e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996212e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.996337e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.996337e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997118e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.998266e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.998266e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998335e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998507e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998549e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998835e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999040e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.999179e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999233e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999267e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999293e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.999392e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999463e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999500e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999529e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999549e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999612e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999617e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999636e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999636e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999683e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999699e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999752e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999786e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999787e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999787e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999801e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999816e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999836e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999864e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999890e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999913e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999925e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999925e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999936e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999945e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999945e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999948e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999948e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999963e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999973e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999978e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999981e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999981e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999982e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999983e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999988e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999989e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999993e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999993e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999994e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.332268e-15 | 14.875 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.215650e-15 | 14.085 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.010303e-14 | 13.996 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.137801e-13 | 12.383 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.965228e-13 | 12.224 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.327783e-13 | 12.079 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.982015e-13 | 12.001 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.982015e-13 | 12.001 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.016387e-12 | 11.695 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.472778e-12 | 11.459 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.015321e-12 | 11.300 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.015321e-12 | 11.300 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.770073e-12 | 11.321 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.755129e-11 | 10.756 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.355893e-11 | 10.474 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.668721e-11 | 10.435 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.981726e-11 | 10.156 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.051178e-10 | 9.978 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.535830e-10 | 9.814 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.609008e-10 | 9.793 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.159686e-10 | 9.666 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.408654e-10 | 9.618 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.409727e-10 | 9.467 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.262670e-10 | 9.279 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.061655e-10 | 9.217 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.948605e-09 | 8.710 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.725344e-09 | 8.429 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.031057e-09 | 8.395 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.882200e-09 | 8.411 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.349962e-09 | 8.362 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.095294e-09 | 8.293 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.356283e-09 | 8.271 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.607763e-09 | 8.251 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.681450e-09 | 8.175 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.056207e-09 | 8.151 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.192526e-09 | 8.143 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.366977e-09 | 8.133 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.999926e-09 | 8.097 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.042974e-08 | 7.982 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.078716e-08 | 7.967 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.117830e-08 | 7.952 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.122302e-08 | 7.950 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.170934e-08 | 7.931 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.194820e-08 | 7.923 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.388349e-08 | 7.858 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.426680e-08 | 7.846 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.426680e-08 | 7.846 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.368236e-08 | 7.864 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.203748e-08 | 7.657 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.893013e-08 | 7.539 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.364211e-08 | 7.473 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.866663e-08 | 7.413 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.106528e-08 | 7.387 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.354102e-08 | 7.361 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.601060e-08 | 7.337 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.946351e-08 | 7.306 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.208598e-08 | 7.283 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.188762e-08 | 7.208 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.452899e-08 | 7.190 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.015857e-08 | 7.096 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.985697e-08 | 7.046 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.520241e-08 | 7.021 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.143996e-07 | 6.942 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.198180e-07 | 6.921 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.496059e-07 | 6.825 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.666541e-07 | 6.778 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.674366e-07 | 6.776 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.124216e-07 | 6.673 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.024499e-07 | 6.519 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.304078e-07 | 6.481 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.891811e-07 | 6.410 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.420927e-07 | 6.266 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.938738e-07 | 6.159 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.985343e-07 | 6.046 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.995482e-07 | 6.046 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.911278e-07 | 6.004 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.002432e-06 | 5.999 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.002432e-06 | 5.999 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.008249e-06 | 5.996 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.159903e-06 | 5.936 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.224597e-06 | 5.912 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.283559e-06 | 5.892 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.606528e-06 | 5.794 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.718036e-06 | 5.765 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.826140e-06 | 5.738 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.901202e-06 | 5.721 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.018692e-06 | 5.695 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.043791e-06 | 5.690 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.113745e-06 | 5.675 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.160440e-06 | 5.665 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.454337e-06 | 5.610 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.583377e-06 | 5.588 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.762638e-06 | 5.559 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.642041e-06 | 5.578 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.882227e-06 | 5.540 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.902352e-06 | 5.537 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.929162e-06 | 5.533 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.121836e-06 | 5.506 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.363698e-06 | 5.473 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.513887e-06 | 5.454 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.588905e-06 | 5.445 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.096659e-06 | 5.388 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.281394e-06 | 5.368 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.666617e-06 | 5.331 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.238222e-06 | 5.281 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.703056e-06 | 5.244 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.565021e-06 | 5.255 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.394537e-06 | 5.268 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.968733e-06 | 5.224 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.038172e-06 | 5.219 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.396463e-06 | 5.076 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.878880e-06 | 5.052 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.011804e-05 | 4.995 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.015708e-05 | 4.993 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.028850e-05 | 4.988 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.095641e-05 | 4.960 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.160963e-05 | 4.935 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.183266e-05 | 4.927 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.232147e-05 | 4.909 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.240956e-05 | 4.906 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.372371e-05 | 4.863 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.445392e-05 | 4.840 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.516022e-05 | 4.819 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.539720e-05 | 4.813 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.562809e-05 | 4.806 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.593000e-05 | 4.798 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.825683e-05 | 4.739 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.879877e-05 | 4.726 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.954682e-05 | 4.709 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.018100e-05 | 4.695 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.032413e-05 | 4.692 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.079615e-05 | 4.682 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.202377e-05 | 4.657 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.556447e-05 | 4.592 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.615744e-05 | 4.582 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.747626e-05 | 4.561 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.769524e-05 | 4.558 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.140023e-05 | 4.503 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.173389e-05 | 4.498 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.276059e-05 | 4.485 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.276059e-05 | 4.485 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.328020e-05 | 4.478 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.357268e-05 | 4.474 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.629963e-05 | 4.440 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.509458e-05 | 4.455 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.645404e-05 | 4.438 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.746687e-05 | 4.426 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.801052e-05 | 4.420 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.801052e-05 | 4.420 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.143832e-05 | 4.383 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.511411e-05 | 4.346 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.070162e-05 | 4.295 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.144723e-05 | 4.289 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.386631e-05 | 4.269 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.442599e-05 | 4.264 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.689458e-05 | 4.245 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.012326e-05 | 4.221 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.077445e-05 | 4.216 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.367122e-05 | 4.196 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.738264e-05 | 4.171 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.738264e-05 | 4.171 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.544334e-05 | 4.184 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.152891e-05 | 4.146 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.189081e-05 | 4.143 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.261583e-05 | 4.139 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.388273e-05 | 4.131 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.396064e-05 | 4.131 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.396064e-05 | 4.131 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.529285e-05 | 4.123 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.557718e-05 | 4.122 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.161553e-05 | 4.088 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.161553e-05 | 4.088 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.161553e-05 | 4.088 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.172346e-05 | 4.088 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.457477e-05 | 4.073 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.541294e-05 | 4.068 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.530615e-05 | 4.021 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.331546e-05 | 4.030 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.038843e-04 | 3.983 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.050679e-04 | 3.979 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.108607e-04 | 3.955 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.171541e-04 | 3.931 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.172337e-04 | 3.931 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.172337e-04 | 3.931 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.172337e-04 | 3.931 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.172337e-04 | 3.931 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.314532e-04 | 3.881 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.403986e-04 | 3.853 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.466373e-04 | 3.834 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.471738e-04 | 3.832 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.486645e-04 | 3.828 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.593486e-04 | 3.798 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.680662e-04 | 3.775 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.680662e-04 | 3.775 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.682894e-04 | 3.774 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.896920e-04 | 3.722 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.968711e-04 | 3.706 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.955706e-04 | 3.709 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.839547e-04 | 3.735 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.842820e-04 | 3.735 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.799286e-04 | 3.745 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.038548e-04 | 3.691 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.147878e-04 | 3.668 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.336182e-04 | 3.631 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.336182e-04 | 3.631 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.399955e-04 | 3.620 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.400717e-04 | 3.620 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.419604e-04 | 3.616 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.419604e-04 | 3.616 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.472754e-04 | 3.607 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.615024e-04 | 3.583 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.615024e-04 | 3.583 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.654550e-04 | 3.576 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.654550e-04 | 3.576 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.900129e-04 | 3.538 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.034591e-04 | 3.518 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.108934e-04 | 3.507 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.503381e-04 | 3.456 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.647620e-04 | 3.438 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.705589e-04 | 3.431 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.075576e-04 | 3.390 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.322405e-04 | 3.364 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.525440e-04 | 3.344 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.763355e-04 | 3.322 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.398394e-04 | 3.357 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.967461e-04 | 3.304 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.979619e-04 | 3.303 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.852428e-04 | 3.314 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.067515e-04 | 3.295 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.113565e-04 | 3.291 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.196479e-04 | 3.284 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.200219e-04 | 3.284 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.203399e-04 | 3.284 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.250196e-04 | 3.280 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.516907e-04 | 3.258 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.598759e-04 | 3.252 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.658692e-04 | 3.247 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.884889e-04 | 3.230 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.031029e-04 | 3.220 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.127318e-04 | 3.213 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.127318e-04 | 3.213 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.127318e-04 | 3.213 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.200711e-04 | 3.208 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.344896e-04 | 3.198 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.344896e-04 | 3.198 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.548663e-04 | 3.184 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.661828e-04 | 3.176 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.661828e-04 | 3.176 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.661828e-04 | 3.176 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.847759e-04 | 3.164 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.223922e-04 | 3.141 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.223922e-04 | 3.141 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.223922e-04 | 3.141 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.259702e-04 | 3.139 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.968829e-04 | 3.099 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.968829e-04 | 3.099 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.116339e-04 | 3.091 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.641282e-04 | 3.016 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.641282e-04 | 3.016 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.641282e-04 | 3.016 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.957140e-04 | 3.048 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.165293e-04 | 3.038 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.395329e-04 | 3.076 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.804477e-04 | 3.055 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.493201e-04 | 3.023 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.167084e-04 | 3.038 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.381217e-04 | 3.077 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.827413e-04 | 3.008 | 0 | 0 |
| Translation | R-HSA-72766 | 1.001859e-03 | 2.999 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.042569e-03 | 2.982 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.044147e-03 | 2.981 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.082580e-03 | 2.966 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.152828e-03 | 2.938 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.155368e-03 | 2.937 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.166279e-03 | 2.933 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.204185e-03 | 2.919 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.222840e-03 | 2.913 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.274910e-03 | 2.895 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.295616e-03 | 2.888 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.295629e-03 | 2.888 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.320034e-03 | 2.879 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.320034e-03 | 2.879 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.320034e-03 | 2.879 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.320034e-03 | 2.879 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.322857e-03 | 2.878 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.396874e-03 | 2.855 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.461986e-03 | 2.835 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.489952e-03 | 2.827 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.506706e-03 | 2.822 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.509893e-03 | 2.821 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.579952e-03 | 2.801 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.648131e-03 | 2.783 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.670727e-03 | 2.777 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.722230e-03 | 2.764 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.953423e-03 | 2.709 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.953423e-03 | 2.709 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.953423e-03 | 2.709 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.953423e-03 | 2.709 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.131520e-03 | 2.671 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.931896e-03 | 2.714 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.180787e-03 | 2.661 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.187074e-03 | 2.660 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.115645e-03 | 2.675 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.153958e-03 | 2.667 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.234706e-03 | 2.651 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.234706e-03 | 2.651 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.239984e-03 | 2.650 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.282615e-03 | 2.642 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.363821e-03 | 2.626 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.383710e-03 | 2.623 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.426274e-03 | 2.615 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.427248e-03 | 2.615 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.427248e-03 | 2.615 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.583780e-03 | 2.588 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.593396e-03 | 2.586 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.596545e-03 | 2.586 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.618454e-03 | 2.582 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.667946e-03 | 2.574 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.840146e-03 | 2.547 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.930166e-03 | 2.533 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.975323e-03 | 2.526 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.033703e-03 | 2.518 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.033703e-03 | 2.518 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.084797e-03 | 2.511 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.173611e-03 | 2.498 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.174135e-03 | 2.498 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.174135e-03 | 2.498 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.227110e-03 | 2.491 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.232489e-03 | 2.490 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.232489e-03 | 2.490 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.371011e-03 | 2.472 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.402224e-03 | 2.468 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.463147e-03 | 2.461 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.463147e-03 | 2.461 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.516740e-03 | 2.454 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.617961e-03 | 2.442 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.636335e-03 | 2.439 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.742592e-03 | 2.427 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.748933e-03 | 2.426 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.758755e-03 | 2.425 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.758755e-03 | 2.425 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.758755e-03 | 2.425 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.768845e-03 | 2.424 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.769674e-03 | 2.424 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.844785e-03 | 2.415 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.869820e-03 | 2.412 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.891112e-03 | 2.410 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.891112e-03 | 2.410 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.891112e-03 | 2.410 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.063171e-03 | 2.391 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.074601e-03 | 2.390 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.311497e-03 | 2.365 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.137226e-03 | 2.289 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.137226e-03 | 2.289 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.654884e-03 | 2.332 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.910274e-03 | 2.309 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.555836e-03 | 2.341 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.683935e-03 | 2.329 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.683935e-03 | 2.329 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.555836e-03 | 2.341 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.683935e-03 | 2.329 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.137226e-03 | 2.289 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.157082e-03 | 2.288 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.945833e-03 | 2.306 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.592636e-03 | 2.338 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.224944e-03 | 2.374 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.801766e-03 | 2.319 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.447924e-03 | 2.352 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.305817e-03 | 2.275 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.310318e-03 | 2.275 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.310318e-03 | 2.275 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.535500e-03 | 2.257 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.535500e-03 | 2.257 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.535500e-03 | 2.257 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.542535e-03 | 2.256 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.625288e-03 | 2.250 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.625288e-03 | 2.250 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.625288e-03 | 2.250 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.630329e-03 | 2.249 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.931661e-03 | 2.227 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.931661e-03 | 2.227 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.931661e-03 | 2.227 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.939730e-03 | 2.226 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.007453e-03 | 2.221 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.155249e-03 | 2.211 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.155249e-03 | 2.211 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.199967e-03 | 2.208 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.467065e-03 | 2.189 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.467065e-03 | 2.189 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.545235e-03 | 2.184 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.545235e-03 | 2.184 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.684432e-03 | 2.175 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.723537e-03 | 2.172 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.733829e-03 | 2.172 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.740558e-03 | 2.171 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.800758e-03 | 2.167 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.464189e-03 | 2.127 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.464189e-03 | 2.127 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.630803e-03 | 2.117 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.700305e-03 | 2.113 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.710343e-03 | 2.113 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.978700e-03 | 2.098 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.022961e-03 | 2.096 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.022961e-03 | 2.096 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.054143e-03 | 2.094 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 8.086419e-03 | 2.092 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 8.086419e-03 | 2.092 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.161621e-03 | 2.088 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.161621e-03 | 2.088 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.197798e-03 | 2.086 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.197798e-03 | 2.086 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.442077e-03 | 2.074 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.562502e-03 | 2.067 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.003721e-03 | 2.046 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.003721e-03 | 2.046 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.131443e-03 | 2.039 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.411474e-03 | 2.026 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.411474e-03 | 2.026 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.451422e-03 | 2.025 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.492235e-03 | 2.023 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.492235e-03 | 2.023 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.492235e-03 | 2.023 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.492235e-03 | 2.023 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.522838e-03 | 2.021 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.686116e-03 | 2.014 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.726580e-03 | 2.012 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.749051e-03 | 2.011 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.851929e-03 | 2.006 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.856336e-03 | 2.006 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.897315e-03 | 2.004 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.952134e-03 | 2.002 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.021829e-02 | 1.991 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.046918e-02 | 1.980 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.049736e-02 | 1.979 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.355697e-02 | 1.868 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.277608e-02 | 1.894 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.277608e-02 | 1.894 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.110982e-02 | 1.954 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.409580e-02 | 1.851 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.354565e-02 | 1.868 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.304219e-02 | 1.885 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.074002e-02 | 1.969 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.351483e-02 | 1.869 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.354565e-02 | 1.868 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.139940e-02 | 1.943 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.060745e-02 | 1.974 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.409580e-02 | 1.851 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.178537e-02 | 1.929 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.277608e-02 | 1.894 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.198248e-02 | 1.921 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.399650e-02 | 1.854 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.277131e-02 | 1.894 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.103793e-02 | 1.957 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.074002e-02 | 1.969 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.354565e-02 | 1.868 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.110982e-02 | 1.954 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.150022e-02 | 1.939 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.198248e-02 | 1.921 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.356538e-02 | 1.868 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.354565e-02 | 1.868 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.185552e-02 | 1.926 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.120668e-02 | 1.951 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.293317e-02 | 1.888 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.213784e-02 | 1.916 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.178537e-02 | 1.929 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.110982e-02 | 1.954 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.417129e-02 | 1.849 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.424485e-02 | 1.846 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.446847e-02 | 1.840 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.489517e-02 | 1.827 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.493762e-02 | 1.826 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.493762e-02 | 1.826 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.493762e-02 | 1.826 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.494467e-02 | 1.826 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.494467e-02 | 1.826 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.494467e-02 | 1.826 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.494467e-02 | 1.826 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.583875e-02 | 1.800 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.636627e-02 | 1.786 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.654984e-02 | 1.781 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.726282e-02 | 1.763 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.739412e-02 | 1.760 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.757710e-02 | 1.755 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.757710e-02 | 1.755 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.770693e-02 | 1.752 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.802133e-02 | 1.744 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.811635e-02 | 1.742 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.835237e-02 | 1.736 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.866894e-02 | 1.729 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.870316e-02 | 1.728 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.878782e-02 | 1.726 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.887740e-02 | 1.724 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.887740e-02 | 1.724 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.887740e-02 | 1.724 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.920453e-02 | 1.717 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.951588e-02 | 1.710 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.951588e-02 | 1.710 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.960271e-02 | 1.708 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.981029e-02 | 1.703 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.983807e-02 | 1.703 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.983807e-02 | 1.703 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.028628e-02 | 1.693 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.057803e-02 | 1.687 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.074457e-02 | 1.683 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.075707e-02 | 1.683 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.083114e-02 | 1.681 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.083114e-02 | 1.681 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.083114e-02 | 1.681 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.088468e-02 | 1.680 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.093970e-02 | 1.679 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.093970e-02 | 1.679 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.093970e-02 | 1.679 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.093970e-02 | 1.679 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.128940e-02 | 1.672 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.149140e-02 | 1.668 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.168593e-02 | 1.664 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.168593e-02 | 1.664 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.168593e-02 | 1.664 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.192711e-02 | 1.659 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.210408e-02 | 1.656 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.263643e-02 | 1.645 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.265273e-02 | 1.645 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.274151e-02 | 1.643 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.274151e-02 | 1.643 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.291208e-02 | 1.640 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.291208e-02 | 1.640 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.341508e-02 | 1.631 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.408903e-02 | 1.618 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.408903e-02 | 1.618 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.408903e-02 | 1.618 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.408903e-02 | 1.618 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.444430e-02 | 1.612 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.444430e-02 | 1.612 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.444430e-02 | 1.612 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.448511e-02 | 1.611 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.448511e-02 | 1.611 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.448511e-02 | 1.611 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.573528e-02 | 1.589 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.582472e-02 | 1.588 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.589589e-02 | 1.587 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.589589e-02 | 1.587 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.634040e-02 | 1.579 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.634040e-02 | 1.579 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.697585e-02 | 1.569 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.765561e-02 | 1.558 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.772721e-02 | 1.557 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.772721e-02 | 1.557 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.794916e-02 | 1.554 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.803416e-02 | 1.552 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.805360e-02 | 1.552 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.814863e-02 | 1.551 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.885931e-02 | 1.540 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.979323e-02 | 1.526 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.979323e-02 | 1.526 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.979323e-02 | 1.526 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.033353e-02 | 1.518 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.101226e-02 | 1.508 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.101226e-02 | 1.508 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.107952e-02 | 1.508 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.107952e-02 | 1.508 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.167734e-02 | 1.499 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.267217e-02 | 1.486 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.267217e-02 | 1.486 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.369085e-02 | 1.472 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.471739e-02 | 1.459 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.589184e-02 | 1.445 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.617037e-02 | 1.442 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.669120e-02 | 1.435 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.693175e-02 | 1.433 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.716585e-02 | 1.430 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.762752e-02 | 1.424 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.768213e-02 | 1.424 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.835685e-02 | 1.416 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.863580e-02 | 1.413 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.863580e-02 | 1.413 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.863580e-02 | 1.413 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.802264e-02 | 1.236 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 5.802264e-02 | 1.236 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.365967e-02 | 1.360 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.197311e-02 | 1.377 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.197311e-02 | 1.377 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.197311e-02 | 1.377 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.572778e-02 | 1.254 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.572778e-02 | 1.254 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.679683e-02 | 1.330 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.735619e-02 | 1.325 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.735619e-02 | 1.325 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.720091e-02 | 1.243 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.720091e-02 | 1.243 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.432626e-02 | 1.265 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.685289e-02 | 1.245 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.133829e-02 | 1.290 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.133829e-02 | 1.290 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.723116e-02 | 1.242 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.712671e-02 | 1.243 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.724856e-02 | 1.242 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.518848e-02 | 1.345 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.944589e-02 | 1.306 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.064798e-02 | 1.391 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.486928e-02 | 1.348 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.679683e-02 | 1.330 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.587169e-02 | 1.338 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.500271e-02 | 1.260 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.500271e-02 | 1.260 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.064798e-02 | 1.391 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.027571e-02 | 1.299 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.488671e-02 | 1.261 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.968305e-02 | 1.401 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.365967e-02 | 1.360 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.365967e-02 | 1.360 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.390167e-02 | 1.268 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.587169e-02 | 1.338 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.073369e-02 | 1.390 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.802264e-02 | 1.236 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.924039e-02 | 1.308 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.062244e-02 | 1.296 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.062244e-02 | 1.296 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.746971e-02 | 1.324 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.190682e-02 | 1.378 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.626938e-02 | 1.335 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.523443e-02 | 1.345 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.133829e-02 | 1.290 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.958037e-02 | 1.403 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.679683e-02 | 1.330 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.486928e-02 | 1.348 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.646708e-02 | 1.333 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.698601e-02 | 1.244 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.197311e-02 | 1.377 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.319888e-02 | 1.365 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.720091e-02 | 1.243 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.449239e-02 | 1.352 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.128499e-02 | 1.384 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.587169e-02 | 1.338 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.587169e-02 | 1.338 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.735619e-02 | 1.325 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 5.572778e-02 | 1.254 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.190682e-02 | 1.378 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.839703e-02 | 1.234 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.839703e-02 | 1.234 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.839703e-02 | 1.234 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.839703e-02 | 1.234 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.026917e-02 | 1.220 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.147290e-02 | 1.211 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.229212e-02 | 1.206 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.295653e-02 | 1.201 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.309259e-02 | 1.200 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.321998e-02 | 1.199 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.321998e-02 | 1.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.321998e-02 | 1.199 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.356001e-02 | 1.197 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.366043e-02 | 1.196 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.689681e-02 | 1.175 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.775737e-02 | 1.169 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.818339e-02 | 1.166 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.818339e-02 | 1.166 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.818339e-02 | 1.166 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.828447e-02 | 1.166 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.968988e-02 | 1.157 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.968988e-02 | 1.157 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.968988e-02 | 1.157 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.078714e-02 | 1.150 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.135177e-02 | 1.147 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.149280e-02 | 1.146 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.149280e-02 | 1.146 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.149280e-02 | 1.146 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.149280e-02 | 1.146 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.161355e-02 | 1.145 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.161355e-02 | 1.145 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.161355e-02 | 1.145 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.161355e-02 | 1.145 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.161355e-02 | 1.145 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.161355e-02 | 1.145 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.288283e-02 | 1.137 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.390953e-02 | 1.131 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.390953e-02 | 1.131 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.623101e-02 | 1.118 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.623101e-02 | 1.118 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.623101e-02 | 1.118 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.850601e-02 | 1.105 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.850601e-02 | 1.105 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.891943e-02 | 1.103 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.143746e-02 | 1.089 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.507423e-02 | 1.070 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.523304e-02 | 1.069 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.523304e-02 | 1.069 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.588532e-02 | 1.066 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.606114e-02 | 1.065 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.606114e-02 | 1.065 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.606114e-02 | 1.065 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.611371e-02 | 1.065 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.611371e-02 | 1.065 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 8.611371e-02 | 1.065 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 8.611371e-02 | 1.065 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.673214e-02 | 1.062 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.673214e-02 | 1.062 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.737047e-02 | 1.059 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.737047e-02 | 1.059 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.808500e-02 | 1.055 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.808500e-02 | 1.055 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.808500e-02 | 1.055 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.954819e-02 | 1.048 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.954819e-02 | 1.048 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.954819e-02 | 1.048 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.954819e-02 | 1.048 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.954819e-02 | 1.048 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.101047e-02 | 1.041 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.128682e-02 | 1.040 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.290779e-02 | 1.032 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.336708e-02 | 1.030 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.336708e-02 | 1.030 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.336708e-02 | 1.030 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.354668e-02 | 1.029 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.497748e-02 | 1.022 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.497748e-02 | 1.022 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 9.497748e-02 | 1.022 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.632089e-02 | 1.016 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.674933e-02 | 1.014 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.714675e-02 | 1.013 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.716954e-02 | 1.012 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.716954e-02 | 1.012 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.826458e-02 | 1.008 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.826458e-02 | 1.008 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.826458e-02 | 1.008 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.842923e-02 | 1.007 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.006612e-01 | 0.997 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.019582e-01 | 0.992 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.020571e-01 | 0.991 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.020571e-01 | 0.991 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.020571e-01 | 0.991 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.020571e-01 | 0.991 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.039938e-01 | 0.983 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.047098e-01 | 0.980 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.071512e-01 | 0.970 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.072741e-01 | 0.970 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.078873e-01 | 0.967 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.093037e-01 | 0.961 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.094101e-01 | 0.961 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.094101e-01 | 0.961 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.101111e-01 | 0.958 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.101111e-01 | 0.958 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.115625e-01 | 0.952 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.119660e-01 | 0.951 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.119660e-01 | 0.951 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.160729e-01 | 0.935 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.160729e-01 | 0.935 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.194163e-01 | 0.923 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.194163e-01 | 0.923 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.194163e-01 | 0.923 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.209593e-01 | 0.917 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.209593e-01 | 0.917 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.209593e-01 | 0.917 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.209593e-01 | 0.917 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.209593e-01 | 0.917 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.209593e-01 | 0.917 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.209593e-01 | 0.917 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.209593e-01 | 0.917 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.227855e-01 | 0.911 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.232872e-01 | 0.909 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.232872e-01 | 0.909 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.237916e-01 | 0.907 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.239436e-01 | 0.907 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.286822e-01 | 0.890 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.287978e-01 | 0.890 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.292983e-01 | 0.888 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.272936e-01 | 0.643 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.272936e-01 | 0.643 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.272936e-01 | 0.643 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.272936e-01 | 0.643 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.272936e-01 | 0.643 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.272936e-01 | 0.643 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.272936e-01 | 0.643 | 0 | 0 |
| Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | R-HSA-5619110 | 2.272936e-01 | 0.643 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.367762e-01 | 0.864 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.817076e-01 | 0.741 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.817076e-01 | 0.741 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.817076e-01 | 0.741 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.403573e-01 | 0.853 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.403573e-01 | 0.853 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.403573e-01 | 0.853 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.403573e-01 | 0.853 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.284030e-01 | 0.641 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.284030e-01 | 0.641 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 2.284030e-01 | 0.641 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.284030e-01 | 0.641 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.284030e-01 | 0.641 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.284030e-01 | 0.641 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.284030e-01 | 0.641 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.708498e-01 | 0.767 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.708498e-01 | 0.767 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.708498e-01 | 0.767 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 1.708498e-01 | 0.767 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.310466e-01 | 0.883 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.310466e-01 | 0.883 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.542815e-01 | 0.812 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.030076e-01 | 0.692 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.030076e-01 | 0.692 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 2.030076e-01 | 0.692 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.030076e-01 | 0.692 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.380576e-01 | 0.860 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.380576e-01 | 0.860 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.364105e-01 | 0.626 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.364105e-01 | 0.626 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.364105e-01 | 0.626 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.578858e-01 | 0.802 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.578858e-01 | 0.802 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.047684e-01 | 0.689 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.047684e-01 | 0.689 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.047684e-01 | 0.689 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.787944e-01 | 0.748 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.386132e-01 | 0.858 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.316127e-01 | 0.635 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.316127e-01 | 0.635 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.006685e-01 | 0.698 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.703076e-01 | 0.769 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.703076e-01 | 0.769 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.233874e-01 | 0.651 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.233874e-01 | 0.651 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.233874e-01 | 0.651 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.233874e-01 | 0.651 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.233874e-01 | 0.651 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.592502e-01 | 0.586 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.304482e-01 | 0.885 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.652964e-01 | 0.782 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.583369e-01 | 0.800 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.704712e-01 | 0.768 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.010967e-01 | 0.697 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.912309e-01 | 0.718 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.360475e-01 | 0.866 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.248052e-01 | 0.648 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.048268e-01 | 0.689 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.708498e-01 | 0.767 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.346299e-01 | 0.630 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.006685e-01 | 0.698 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.872402e-01 | 0.728 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.364105e-01 | 0.626 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.556540e-01 | 0.592 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.789227e-01 | 0.747 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.382229e-01 | 0.623 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.364105e-01 | 0.626 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.316127e-01 | 0.635 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.316127e-01 | 0.635 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.346299e-01 | 0.630 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.061942e-01 | 0.686 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.300081e-01 | 0.886 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.542815e-01 | 0.812 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.141752e-01 | 0.669 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.284030e-01 | 0.641 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.789227e-01 | 0.747 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.364105e-01 | 0.626 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.364105e-01 | 0.626 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.396976e-01 | 0.855 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.047684e-01 | 0.689 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.628770e-01 | 0.788 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.589257e-01 | 0.799 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.346299e-01 | 0.630 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.542815e-01 | 0.812 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.817076e-01 | 0.741 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.787944e-01 | 0.748 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.556540e-01 | 0.592 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.488377e-01 | 0.827 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.787944e-01 | 0.748 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.765748e-01 | 0.753 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.765748e-01 | 0.753 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.462760e-01 | 0.609 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.708498e-01 | 0.767 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.542815e-01 | 0.812 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.141752e-01 | 0.669 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.636588e-01 | 0.786 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.380576e-01 | 0.860 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.006685e-01 | 0.698 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.508297e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.716329e-01 | 0.765 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.787944e-01 | 0.748 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.407838e-01 | 0.851 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.403573e-01 | 0.853 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.289375e-01 | 0.640 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.872402e-01 | 0.728 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.351186e-01 | 0.869 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.526138e-01 | 0.816 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.542001e-01 | 0.812 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.618930e-01 | 0.791 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.263470e-01 | 0.645 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.417315e-01 | 0.617 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.787944e-01 | 0.748 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.539753e-01 | 0.595 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.753107e-01 | 0.756 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.272936e-01 | 0.643 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.367762e-01 | 0.864 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.284030e-01 | 0.641 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.030076e-01 | 0.692 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.364105e-01 | 0.626 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.326527e-01 | 0.877 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.592502e-01 | 0.586 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.468267e-01 | 0.608 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.361991e-01 | 0.866 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.517884e-01 | 0.819 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.616733e-01 | 0.791 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.382229e-01 | 0.623 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.386369e-01 | 0.622 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.798525e-01 | 0.745 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.346299e-01 | 0.630 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.820263e-01 | 0.740 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.310466e-01 | 0.883 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.466543e-01 | 0.834 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.646129e-01 | 0.784 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.753107e-01 | 0.756 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.921102e-01 | 0.716 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.248052e-01 | 0.648 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.817076e-01 | 0.741 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.542815e-01 | 0.812 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.542815e-01 | 0.812 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.316127e-01 | 0.635 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.592502e-01 | 0.586 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.164074e-01 | 0.665 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.396976e-01 | 0.855 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.468267e-01 | 0.608 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.468267e-01 | 0.608 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.526138e-01 | 0.816 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.304482e-01 | 0.885 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.468267e-01 | 0.608 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.403573e-01 | 0.853 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.284030e-01 | 0.641 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.030076e-01 | 0.692 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.047684e-01 | 0.689 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.462760e-01 | 0.609 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.789227e-01 | 0.747 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.592502e-01 | 0.586 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.503200e-01 | 0.602 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.872402e-01 | 0.728 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 2.284030e-01 | 0.641 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.609274e-01 | 0.583 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.609274e-01 | 0.583 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.609274e-01 | 0.583 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.640248e-01 | 0.578 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.640248e-01 | 0.578 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.650683e-01 | 0.577 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.657007e-01 | 0.576 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.666451e-01 | 0.574 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.674363e-01 | 0.573 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.706636e-01 | 0.568 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.706636e-01 | 0.568 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.706636e-01 | 0.568 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.706636e-01 | 0.568 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.706636e-01 | 0.568 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.706636e-01 | 0.568 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.706636e-01 | 0.568 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.706636e-01 | 0.568 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.725003e-01 | 0.565 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.725003e-01 | 0.565 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.725003e-01 | 0.565 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.757790e-01 | 0.559 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.757790e-01 | 0.559 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.757790e-01 | 0.559 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.757790e-01 | 0.559 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.757790e-01 | 0.559 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.757790e-01 | 0.559 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.771612e-01 | 0.557 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.771612e-01 | 0.557 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.771612e-01 | 0.557 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.771612e-01 | 0.557 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.771612e-01 | 0.557 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.801717e-01 | 0.553 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.805347e-01 | 0.552 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.814145e-01 | 0.551 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.825900e-01 | 0.549 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.872972e-01 | 0.542 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.874805e-01 | 0.541 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.874805e-01 | 0.541 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.874805e-01 | 0.541 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.874805e-01 | 0.541 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.876984e-01 | 0.541 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.953642e-01 | 0.530 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.953642e-01 | 0.530 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.990646e-01 | 0.524 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.990646e-01 | 0.524 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.990646e-01 | 0.524 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.997630e-01 | 0.523 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.005558e-01 | 0.522 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.054038e-01 | 0.515 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.054038e-01 | 0.515 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.054038e-01 | 0.515 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.054038e-01 | 0.515 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.147613e-01 | 0.502 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.147613e-01 | 0.502 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.161105e-01 | 0.500 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.171790e-01 | 0.499 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.192375e-01 | 0.496 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.202144e-01 | 0.495 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.207705e-01 | 0.494 | 0 | 0 |
| Beta-ketothiolase deficiency | R-HSA-9915355 | 3.207705e-01 | 0.494 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.207705e-01 | 0.494 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.207705e-01 | 0.494 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.207705e-01 | 0.494 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.207705e-01 | 0.494 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.207705e-01 | 0.494 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.207705e-01 | 0.494 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.207705e-01 | 0.494 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.207705e-01 | 0.494 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.207705e-01 | 0.494 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.207705e-01 | 0.494 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.229882e-01 | 0.491 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.229882e-01 | 0.491 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.229882e-01 | 0.491 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.229882e-01 | 0.491 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.229882e-01 | 0.491 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.229882e-01 | 0.491 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.229882e-01 | 0.491 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 3.229882e-01 | 0.491 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.229882e-01 | 0.491 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.229882e-01 | 0.491 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.266909e-01 | 0.486 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.311731e-01 | 0.480 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.345282e-01 | 0.476 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.381293e-01 | 0.471 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.389912e-01 | 0.470 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.403033e-01 | 0.468 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.403033e-01 | 0.468 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.403033e-01 | 0.468 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.403033e-01 | 0.468 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.403033e-01 | 0.468 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.403033e-01 | 0.468 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.403033e-01 | 0.468 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.403033e-01 | 0.468 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.403033e-01 | 0.468 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.403033e-01 | 0.468 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.403033e-01 | 0.468 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.403033e-01 | 0.468 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.403033e-01 | 0.468 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.436081e-01 | 0.464 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.449578e-01 | 0.462 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.449578e-01 | 0.462 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.449578e-01 | 0.462 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.452920e-01 | 0.462 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.452920e-01 | 0.462 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.505744e-01 | 0.455 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.533623e-01 | 0.452 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.571810e-01 | 0.447 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.617889e-01 | 0.442 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.662957e-01 | 0.436 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.693780e-01 | 0.433 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.693780e-01 | 0.433 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.693780e-01 | 0.433 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 3.693780e-01 | 0.433 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.693780e-01 | 0.433 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.693780e-01 | 0.433 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.693780e-01 | 0.433 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.693780e-01 | 0.433 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.704829e-01 | 0.431 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.738518e-01 | 0.427 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.738518e-01 | 0.427 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.738518e-01 | 0.427 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.738518e-01 | 0.427 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.738518e-01 | 0.427 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.744538e-01 | 0.427 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.750712e-01 | 0.426 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.763432e-01 | 0.424 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.764387e-01 | 0.424 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.764387e-01 | 0.424 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.764387e-01 | 0.424 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.818017e-01 | 0.418 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.818017e-01 | 0.418 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.818017e-01 | 0.418 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.818017e-01 | 0.418 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.818017e-01 | 0.418 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.824910e-01 | 0.417 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.824910e-01 | 0.417 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.824910e-01 | 0.417 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.875377e-01 | 0.412 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.889376e-01 | 0.410 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.889376e-01 | 0.410 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.889376e-01 | 0.410 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.889376e-01 | 0.410 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.927243e-01 | 0.406 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.956788e-01 | 0.403 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.956788e-01 | 0.403 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.003093e-01 | 0.398 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.026355e-01 | 0.395 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.029440e-01 | 0.395 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.029440e-01 | 0.395 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.029440e-01 | 0.395 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.029440e-01 | 0.395 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.029440e-01 | 0.395 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.029440e-01 | 0.395 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.029440e-01 | 0.395 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.029440e-01 | 0.395 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.029440e-01 | 0.395 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.029440e-01 | 0.395 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.029440e-01 | 0.395 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.029440e-01 | 0.395 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.029440e-01 | 0.395 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.029440e-01 | 0.395 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.029440e-01 | 0.395 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.029440e-01 | 0.395 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.029440e-01 | 0.395 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.029440e-01 | 0.395 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.032260e-01 | 0.394 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.032260e-01 | 0.394 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.032260e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.032260e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.032260e-01 | 0.394 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.069931e-01 | 0.390 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.069931e-01 | 0.390 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.094537e-01 | 0.388 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.094537e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.094537e-01 | 0.388 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.094537e-01 | 0.388 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.144560e-01 | 0.383 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.144560e-01 | 0.383 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.144560e-01 | 0.383 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 4.144560e-01 | 0.383 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.144560e-01 | 0.383 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.144560e-01 | 0.383 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.144560e-01 | 0.383 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.144560e-01 | 0.383 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.144560e-01 | 0.383 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.144560e-01 | 0.383 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.158141e-01 | 0.381 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.207780e-01 | 0.376 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.207780e-01 | 0.376 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.207780e-01 | 0.376 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.207780e-01 | 0.376 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.207780e-01 | 0.376 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.239535e-01 | 0.373 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.311660e-01 | 0.365 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.311660e-01 | 0.365 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.311660e-01 | 0.365 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.311660e-01 | 0.365 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.311660e-01 | 0.365 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.340157e-01 | 0.362 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.341054e-01 | 0.362 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.341054e-01 | 0.362 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.341054e-01 | 0.362 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.341054e-01 | 0.362 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.341054e-01 | 0.362 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.351236e-01 | 0.361 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.376226e-01 | 0.359 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.432329e-01 | 0.353 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.432329e-01 | 0.353 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.432329e-01 | 0.353 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.432329e-01 | 0.353 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.432329e-01 | 0.353 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.432329e-01 | 0.353 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.432329e-01 | 0.353 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.445669e-01 | 0.352 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.445669e-01 | 0.352 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.445669e-01 | 0.352 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.445669e-01 | 0.352 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.456862e-01 | 0.351 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.456862e-01 | 0.351 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.456862e-01 | 0.351 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.498081e-01 | 0.347 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.537539e-01 | 0.343 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.578608e-01 | 0.339 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 4.578608e-01 | 0.339 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.578608e-01 | 0.339 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.578608e-01 | 0.339 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.578608e-01 | 0.339 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.578608e-01 | 0.339 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.578608e-01 | 0.339 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.578608e-01 | 0.339 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.593150e-01 | 0.338 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.604193e-01 | 0.337 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.625094e-01 | 0.335 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.703166e-01 | 0.328 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.721696e-01 | 0.326 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.722866e-01 | 0.326 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.751803e-01 | 0.323 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.751803e-01 | 0.323 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.751803e-01 | 0.323 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.751803e-01 | 0.323 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.751803e-01 | 0.323 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.751803e-01 | 0.323 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.751803e-01 | 0.323 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.751803e-01 | 0.323 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.751803e-01 | 0.323 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.751803e-01 | 0.323 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.762255e-01 | 0.322 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.762255e-01 | 0.322 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.762255e-01 | 0.322 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.762255e-01 | 0.322 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.762255e-01 | 0.322 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.782379e-01 | 0.320 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.786570e-01 | 0.320 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.786570e-01 | 0.320 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.853828e-01 | 0.314 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.853828e-01 | 0.314 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.859281e-01 | 0.313 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.869689e-01 | 0.312 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.869689e-01 | 0.312 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.869689e-01 | 0.312 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.869689e-01 | 0.312 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.945904e-01 | 0.306 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.945904e-01 | 0.306 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.945904e-01 | 0.306 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.959204e-01 | 0.305 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.993377e-01 | 0.302 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.993377e-01 | 0.302 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.993377e-01 | 0.302 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.993377e-01 | 0.302 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.993377e-01 | 0.302 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.054732e-01 | 0.296 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.076460e-01 | 0.294 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.082802e-01 | 0.294 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.082802e-01 | 0.294 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.082802e-01 | 0.294 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.082802e-01 | 0.294 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.097052e-01 | 0.293 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.127442e-01 | 0.290 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.134359e-01 | 0.290 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.140285e-01 | 0.289 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.196668e-01 | 0.284 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.221034e-01 | 0.282 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.252941e-01 | 0.280 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.307554e-01 | 0.275 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.307554e-01 | 0.275 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.386806e-01 | 0.269 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.386806e-01 | 0.269 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.386806e-01 | 0.269 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.386806e-01 | 0.269 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.386806e-01 | 0.269 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 5.386806e-01 | 0.269 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.386806e-01 | 0.269 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.386806e-01 | 0.269 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.386806e-01 | 0.269 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.386806e-01 | 0.269 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.386806e-01 | 0.269 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.386806e-01 | 0.269 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.386806e-01 | 0.269 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.386806e-01 | 0.269 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.386806e-01 | 0.269 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.387178e-01 | 0.269 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.392752e-01 | 0.268 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.392752e-01 | 0.268 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.392752e-01 | 0.268 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.404088e-01 | 0.267 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.404088e-01 | 0.267 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.404088e-01 | 0.267 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.414614e-01 | 0.266 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.414614e-01 | 0.266 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.414614e-01 | 0.266 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.432809e-01 | 0.265 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.478518e-01 | 0.261 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.508149e-01 | 0.259 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.624560e-01 | 0.250 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.646030e-01 | 0.248 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.660379e-01 | 0.247 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.660379e-01 | 0.247 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.660379e-01 | 0.247 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.660379e-01 | 0.247 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.691159e-01 | 0.245 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.691159e-01 | 0.245 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.691159e-01 | 0.245 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.691159e-01 | 0.245 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.691159e-01 | 0.245 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.691159e-01 | 0.245 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.759013e-01 | 0.240 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.759013e-01 | 0.240 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.759013e-01 | 0.240 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.759013e-01 | 0.240 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.759013e-01 | 0.240 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.822219e-01 | 0.235 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.843265e-01 | 0.233 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.868204e-01 | 0.231 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.868204e-01 | 0.231 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.868204e-01 | 0.231 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 5.868204e-01 | 0.231 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.908569e-01 | 0.229 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.945009e-01 | 0.226 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.945009e-01 | 0.226 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.945009e-01 | 0.226 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.945009e-01 | 0.226 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.945009e-01 | 0.226 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.945009e-01 | 0.226 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.945009e-01 | 0.226 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.945009e-01 | 0.226 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.945009e-01 | 0.226 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.945009e-01 | 0.226 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.945009e-01 | 0.226 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.945009e-01 | 0.226 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.945009e-01 | 0.226 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.945009e-01 | 0.226 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.945009e-01 | 0.226 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.945009e-01 | 0.226 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.945009e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.945009e-01 | 0.226 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.957553e-01 | 0.225 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.977314e-01 | 0.223 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.977314e-01 | 0.223 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.977314e-01 | 0.223 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.977314e-01 | 0.223 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.977314e-01 | 0.223 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.084047e-01 | 0.216 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.108433e-01 | 0.214 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.108433e-01 | 0.214 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.108433e-01 | 0.214 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.108433e-01 | 0.214 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.148186e-01 | 0.211 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.148186e-01 | 0.211 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.250727e-01 | 0.204 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.250727e-01 | 0.204 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.293225e-01 | 0.201 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.293225e-01 | 0.201 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.324279e-01 | 0.199 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.378867e-01 | 0.195 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.378867e-01 | 0.195 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.378867e-01 | 0.195 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.424876e-01 | 0.192 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.424876e-01 | 0.192 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.435418e-01 | 0.191 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.435418e-01 | 0.191 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.435418e-01 | 0.191 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.435418e-01 | 0.191 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.435418e-01 | 0.191 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.435418e-01 | 0.191 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.435418e-01 | 0.191 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.435418e-01 | 0.191 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.435698e-01 | 0.191 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.435698e-01 | 0.191 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.435698e-01 | 0.191 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.435698e-01 | 0.191 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.435698e-01 | 0.191 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.435698e-01 | 0.191 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.435698e-01 | 0.191 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.435698e-01 | 0.191 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.435698e-01 | 0.191 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.435698e-01 | 0.191 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.435698e-01 | 0.191 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.435698e-01 | 0.191 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.435698e-01 | 0.191 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.435698e-01 | 0.191 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.435698e-01 | 0.191 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.435698e-01 | 0.191 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.435698e-01 | 0.191 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.435698e-01 | 0.191 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.435698e-01 | 0.191 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.435698e-01 | 0.191 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.435698e-01 | 0.191 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.435698e-01 | 0.191 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.435698e-01 | 0.191 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.435698e-01 | 0.191 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.435698e-01 | 0.191 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.435698e-01 | 0.191 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.435698e-01 | 0.191 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.438486e-01 | 0.191 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.473496e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.495473e-01 | 0.187 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.495473e-01 | 0.187 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.495473e-01 | 0.187 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.495473e-01 | 0.187 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.511091e-01 | 0.186 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.511091e-01 | 0.186 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.511091e-01 | 0.186 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.511091e-01 | 0.186 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.511091e-01 | 0.186 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.555034e-01 | 0.183 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.600351e-01 | 0.180 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.600351e-01 | 0.180 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.625417e-01 | 0.179 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.625417e-01 | 0.179 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.643905e-01 | 0.178 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.740280e-01 | 0.171 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.740280e-01 | 0.171 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.758265e-01 | 0.170 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.758265e-01 | 0.170 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.758265e-01 | 0.170 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.761722e-01 | 0.170 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.761722e-01 | 0.170 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.778292e-01 | 0.169 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.778292e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.784783e-01 | 0.168 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.788308e-01 | 0.168 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.811102e-01 | 0.167 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.821854e-01 | 0.166 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.867034e-01 | 0.163 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.867034e-01 | 0.163 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.867034e-01 | 0.163 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 6.867034e-01 | 0.163 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.867034e-01 | 0.163 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.867034e-01 | 0.163 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.867034e-01 | 0.163 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.867034e-01 | 0.163 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.867034e-01 | 0.163 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.867034e-01 | 0.163 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.867034e-01 | 0.163 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.867034e-01 | 0.163 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.867034e-01 | 0.163 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.867034e-01 | 0.163 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.867034e-01 | 0.163 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 6.895887e-01 | 0.161 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.925270e-01 | 0.160 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.947968e-01 | 0.158 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.947968e-01 | 0.158 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.947968e-01 | 0.158 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.973595e-01 | 0.157 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.973595e-01 | 0.157 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.992248e-01 | 0.155 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.023584e-01 | 0.153 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.023584e-01 | 0.153 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.052402e-01 | 0.152 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.111583e-01 | 0.148 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.213156e-01 | 0.142 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.213156e-01 | 0.142 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.213156e-01 | 0.142 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.213156e-01 | 0.142 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.246194e-01 | 0.140 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.246194e-01 | 0.140 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.246194e-01 | 0.140 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.246194e-01 | 0.140 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.246194e-01 | 0.140 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.246194e-01 | 0.140 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.246194e-01 | 0.140 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.246194e-01 | 0.140 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.246194e-01 | 0.140 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.246194e-01 | 0.140 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.246194e-01 | 0.140 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.286083e-01 | 0.138 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.286083e-01 | 0.138 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.286083e-01 | 0.138 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.286083e-01 | 0.138 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.286083e-01 | 0.138 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.286083e-01 | 0.138 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 7.286083e-01 | 0.138 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.397504e-01 | 0.131 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.421204e-01 | 0.130 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.421204e-01 | 0.130 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.452111e-01 | 0.128 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.528663e-01 | 0.123 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.528663e-01 | 0.123 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.528663e-01 | 0.123 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.528663e-01 | 0.123 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.555718e-01 | 0.122 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.565709e-01 | 0.121 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.565709e-01 | 0.121 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.579487e-01 | 0.120 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.579487e-01 | 0.120 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.579487e-01 | 0.120 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.579487e-01 | 0.120 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.579487e-01 | 0.120 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.579487e-01 | 0.120 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.579487e-01 | 0.120 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.579487e-01 | 0.120 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.579487e-01 | 0.120 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.579487e-01 | 0.120 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.579487e-01 | 0.120 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.616690e-01 | 0.118 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.704876e-01 | 0.113 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.704923e-01 | 0.113 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.731797e-01 | 0.112 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.731797e-01 | 0.112 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.752298e-01 | 0.111 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.752298e-01 | 0.111 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.752298e-01 | 0.111 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 7.752298e-01 | 0.111 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.752298e-01 | 0.111 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.752298e-01 | 0.111 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.752298e-01 | 0.111 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.752298e-01 | 0.111 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.799975e-01 | 0.108 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.799975e-01 | 0.108 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.799975e-01 | 0.108 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.799975e-01 | 0.108 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.872458e-01 | 0.104 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.872458e-01 | 0.104 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.872458e-01 | 0.104 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.872458e-01 | 0.104 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.872458e-01 | 0.104 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.872458e-01 | 0.104 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.872458e-01 | 0.104 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.872458e-01 | 0.104 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.873628e-01 | 0.104 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.888103e-01 | 0.103 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.897408e-01 | 0.103 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.958021e-01 | 0.099 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.958021e-01 | 0.099 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.958021e-01 | 0.099 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.958021e-01 | 0.099 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.960283e-01 | 0.099 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.971474e-01 | 0.098 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.971474e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.971474e-01 | 0.098 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.069789e-01 | 0.093 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.074331e-01 | 0.093 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.129984e-01 | 0.090 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.129984e-01 | 0.090 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.129984e-01 | 0.090 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.129984e-01 | 0.090 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.129984e-01 | 0.090 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.129984e-01 | 0.090 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.129984e-01 | 0.090 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.131638e-01 | 0.090 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.146890e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.146890e-01 | 0.089 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.174740e-01 | 0.088 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.183412e-01 | 0.087 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.280001e-01 | 0.082 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.319971e-01 | 0.080 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.319971e-01 | 0.080 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.319971e-01 | 0.080 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.319971e-01 | 0.080 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.319971e-01 | 0.080 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.347309e-01 | 0.078 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.356351e-01 | 0.078 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.356351e-01 | 0.078 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.356351e-01 | 0.078 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.356351e-01 | 0.078 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.356351e-01 | 0.078 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.356351e-01 | 0.078 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.356351e-01 | 0.078 | 0 | 0 |
| Utilization of Ketone Bodies | R-HSA-77108 | 8.356351e-01 | 0.078 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.356351e-01 | 0.078 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.356351e-01 | 0.078 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.356351e-01 | 0.078 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.356351e-01 | 0.078 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.370701e-01 | 0.077 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.395602e-01 | 0.076 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.416738e-01 | 0.075 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.419910e-01 | 0.075 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.419910e-01 | 0.075 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.419910e-01 | 0.075 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.428564e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.428564e-01 | 0.074 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.446900e-01 | 0.073 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.465740e-01 | 0.072 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.478318e-01 | 0.072 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.478318e-01 | 0.072 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.489106e-01 | 0.071 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.549029e-01 | 0.068 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.549029e-01 | 0.068 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.555327e-01 | 0.068 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.555327e-01 | 0.068 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.555327e-01 | 0.068 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.555327e-01 | 0.068 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.555327e-01 | 0.068 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.555327e-01 | 0.068 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.555327e-01 | 0.068 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.555327e-01 | 0.068 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.555327e-01 | 0.068 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.610063e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.622960e-01 | 0.064 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.622960e-01 | 0.064 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.622960e-01 | 0.064 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.622960e-01 | 0.064 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.630301e-01 | 0.064 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.668823e-01 | 0.062 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.668823e-01 | 0.062 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.673336e-01 | 0.062 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.699164e-01 | 0.061 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.730227e-01 | 0.059 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.730227e-01 | 0.059 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.730227e-01 | 0.059 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.730227e-01 | 0.059 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.730227e-01 | 0.059 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.730227e-01 | 0.059 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.730227e-01 | 0.059 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.730227e-01 | 0.059 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.730227e-01 | 0.059 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.753110e-01 | 0.058 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.754894e-01 | 0.058 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.754894e-01 | 0.058 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.754894e-01 | 0.058 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.754894e-01 | 0.058 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.754894e-01 | 0.058 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.783450e-01 | 0.056 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.855216e-01 | 0.053 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.856479e-01 | 0.053 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.875078e-01 | 0.052 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.883961e-01 | 0.051 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.883961e-01 | 0.051 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.883961e-01 | 0.051 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.883961e-01 | 0.051 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.913805e-01 | 0.050 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.959729e-01 | 0.048 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.984421e-01 | 0.047 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.984421e-01 | 0.047 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.984421e-01 | 0.047 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.019090e-01 | 0.045 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.019090e-01 | 0.045 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.019090e-01 | 0.045 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.019090e-01 | 0.045 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.019090e-01 | 0.045 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.019090e-01 | 0.045 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.019090e-01 | 0.045 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.019090e-01 | 0.045 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.019090e-01 | 0.045 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.019090e-01 | 0.045 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.019090e-01 | 0.045 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.020212e-01 | 0.045 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.075751e-01 | 0.042 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.083786e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.083786e-01 | 0.042 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.083786e-01 | 0.042 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.083786e-01 | 0.042 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.137864e-01 | 0.039 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.137864e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.137864e-01 | 0.039 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.137864e-01 | 0.039 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.137864e-01 | 0.039 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.145638e-01 | 0.039 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.145638e-01 | 0.039 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.165693e-01 | 0.038 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.165693e-01 | 0.038 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.173986e-01 | 0.037 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.173986e-01 | 0.037 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.173986e-01 | 0.037 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.242263e-01 | 0.034 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.242263e-01 | 0.034 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.242263e-01 | 0.034 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.242263e-01 | 0.034 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.242263e-01 | 0.034 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.242263e-01 | 0.034 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.242263e-01 | 0.034 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.242263e-01 | 0.034 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.268837e-01 | 0.033 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.288309e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.288309e-01 | 0.032 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.319067e-01 | 0.031 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.320465e-01 | 0.031 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.329889e-01 | 0.030 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.329889e-01 | 0.030 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.334025e-01 | 0.030 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.334025e-01 | 0.030 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.334025e-01 | 0.030 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.334025e-01 | 0.030 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.334025e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.334025e-01 | 0.030 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.334025e-01 | 0.030 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.334025e-01 | 0.030 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.334025e-01 | 0.030 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.334025e-01 | 0.030 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.334025e-01 | 0.030 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.400250e-01 | 0.027 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.408769e-01 | 0.026 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.408769e-01 | 0.026 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.414171e-01 | 0.026 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.414680e-01 | 0.026 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.414680e-01 | 0.026 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.442668e-01 | 0.025 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.443127e-01 | 0.025 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.449586e-01 | 0.025 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.457631e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.462176e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.462176e-01 | 0.024 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.485570e-01 | 0.023 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.485570e-01 | 0.023 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.485570e-01 | 0.023 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.510090e-01 | 0.022 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.538479e-01 | 0.021 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.547879e-01 | 0.020 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.547879e-01 | 0.020 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.547879e-01 | 0.020 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.547879e-01 | 0.020 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.554442e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.561953e-01 | 0.019 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.568992e-01 | 0.019 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.602643e-01 | 0.018 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.602643e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.602643e-01 | 0.018 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.602643e-01 | 0.018 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.602643e-01 | 0.018 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.602643e-01 | 0.018 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.606619e-01 | 0.017 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.606619e-01 | 0.017 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.618930e-01 | 0.017 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.631467e-01 | 0.016 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.632094e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.646896e-01 | 0.016 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.646896e-01 | 0.016 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.646896e-01 | 0.016 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.646896e-01 | 0.016 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.647345e-01 | 0.016 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.650506e-01 | 0.015 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.650777e-01 | 0.015 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.650777e-01 | 0.015 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.650777e-01 | 0.015 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.650777e-01 | 0.015 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.650777e-01 | 0.015 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.650777e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.650777e-01 | 0.015 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.668999e-01 | 0.015 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.683190e-01 | 0.014 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.683190e-01 | 0.014 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.683190e-01 | 0.014 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.693083e-01 | 0.014 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.693083e-01 | 0.014 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.703057e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.715876e-01 | 0.013 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.730266e-01 | 0.012 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.730266e-01 | 0.012 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.730266e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.730266e-01 | 0.012 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.730266e-01 | 0.012 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.757685e-01 | 0.011 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.757685e-01 | 0.011 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.762946e-01 | 0.010 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.762946e-01 | 0.010 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.762946e-01 | 0.010 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.762946e-01 | 0.010 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.762946e-01 | 0.010 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.762946e-01 | 0.010 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.762946e-01 | 0.010 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.771757e-01 | 0.010 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.791668e-01 | 0.009 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.791668e-01 | 0.009 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.795548e-01 | 0.009 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.814171e-01 | 0.008 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.814813e-01 | 0.008 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.816912e-01 | 0.008 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.816912e-01 | 0.008 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.816912e-01 | 0.008 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.816912e-01 | 0.008 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.824016e-01 | 0.008 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.828034e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.828282e-01 | 0.008 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.836128e-01 | 0.007 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.839098e-01 | 0.007 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.839098e-01 | 0.007 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.839098e-01 | 0.007 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.839098e-01 | 0.007 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.839098e-01 | 0.007 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.839098e-01 | 0.007 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.853366e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.853366e-01 | 0.006 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.858597e-01 | 0.006 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.858597e-01 | 0.006 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.858597e-01 | 0.006 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.869948e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.873620e-01 | 0.006 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.875734e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.875734e-01 | 0.005 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.890795e-01 | 0.005 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.890795e-01 | 0.005 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.890795e-01 | 0.005 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.890795e-01 | 0.005 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.901707e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.902018e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.902018e-01 | 0.004 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.904031e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.905683e-01 | 0.004 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.906292e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.906292e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.910914e-01 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.910914e-01 | 0.004 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.912122e-01 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.915664e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.917681e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.925741e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.925741e-01 | 0.003 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.925887e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.925887e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.933227e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.934872e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.937970e-01 | 0.003 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.939352e-01 | 0.003 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.945599e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.946800e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.946800e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.949706e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.949706e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.955804e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.955804e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.956524e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.960218e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.960261e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.961163e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.965284e-01 | 0.002 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.965873e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.965873e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.965873e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.966328e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.971407e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.972937e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.973248e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.974332e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.976594e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.976844e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.976844e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.978963e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.979653e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.982121e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.982121e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.983154e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.984290e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.984290e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.984749e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.984814e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.986196e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.986196e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.986196e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.987870e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.988964e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.989342e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.990101e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.992593e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.992770e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.993378e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.994112e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.994263e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.994418e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.995096e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996735e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997432e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997744e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998195e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998259e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.998470e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998656e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998737e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998881e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998915e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998994e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999044e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999089e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999130e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999133e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999319e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999382e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.999382e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999382e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999457e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999507e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999575e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999581e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999619e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999632e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999632e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999634e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999663e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999746e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999750e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999778e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999809e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999814e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999851e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999855e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999857e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999869e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999874e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999899e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999899e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999954e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999959e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999966e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999976e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999977e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999984e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999988e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999989e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999989e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |